Endoscopic ultrasound-guided biliary access system

Description

FIELD OF THE INVENTION

The present disclosure generally relates to minimally invasive access devices, and, more particularly, to an endoscopic ultrasound (EUS)-guided access system having a maneuverable catheter assembly configured for providing access to and navigating a desired vessel for subsequent treatment thereof.

BACKGROUND

Diseases and disorders of the gallbladder, pancreas, and bile ducts (e.g., pancreaticobiliary system) are associated with significant morbidity, mortality, and impaired quality of life. Obstructions, tumors, injuries, leakages, and lesions can occur in these structures, which can eventually lead to conditions such as biliary colic, cholecystitis, choledocholithiasis, cholelithiasis, pancreatitis, pancreatic duct stone formations, and chronic abdominal pain. In addition, diseases/disorders of the pancreaticobiliary system may be associated with nutritional disorders, such as malnutrition, obesity, as well as high cholesterol.

FIG. 1 illustrates a portion of the human body, including the pancreaticobiliary system. The liver 100 produces bile, a fluid vital for the digestion of fatty foods. Bile contains salts, cholesterol, various pigments, and waste products such as bilirubin. Bile serves at least two main functions: to get rid of certain waste products; and to aid in digestion by assisting in the emulsification and absorption of fats from the intestines. Bile is collected by a network of ducts that converge at the common hepatic duct 102. While a small quantity of bile drains directly into the lumen of the duodenum 120 (an upper part of the small intestine immediately downstream of the stomach), most bile travels through the common hepatic duct 102 and accumulates within the gallbladder 104. Contraction of the gallbladder 104 forces bile to flow from the gallbladder 104, through the cystic duct 106, and into a large bile duct known as the common bile duct 108. From the common bile duct 108, bile flows through the ampulla of Vater 118 and into the duodenum 120, where the bile mixes and reacts with digesting food.

The pancreas 114 is both an endocrine gland (producing several important hormones, including insulin, glucagon, and somatostatin), as well as an exocrine gland, secreting pancreatic juices containing digestive enzymes that pass to the small intestine. The pancreatic duct 112 joins the common bile duct 108 just prior to the ampulla of Vater 118. Accordingly, pancreatic juices drain through the ampulla of Vater 118 and into the duodenum to further aid in digestion.

The common bile duct and pancreatic duct are essential for providing drainage from the liver, gallbladder, and pancreas. However, in some cases, these ducts may become obstructed as a result of cysts, enlarged lymph nodes, gallstones, inflammation, stricture, or narrowing, of the ducts from scarring, injury from surgery, tumors, or other causes, which can lead to inadequate drainage of bile and/or pancreatic juices.

For example, as shown in FIG. 2, a common problem that arises in the biliary system is the formation of gallstones, a condition called cholelithiasis. Gallstones can form in the gallbladder 104, cystic duct 106, and/or the common bile duct 108. By themselves, gallstones 110 do not necessarily result in disease states. However, stones can cause infection and inflammation, a condition known as cholecystitis, which is generally the result of restricting or blocking the flow of bile from the gallbladder 104 and common bile duct 108, or the fluids secreted by the pancreas 114. When gallstones 110′ become lodged in the common bile duct 108, the condition is known as choledocholithiasis. Symptoms for this condition include pain, nausea and vomiting, and some patients develop jaundice, have dark urine and/or lighter stools, rapid heartbeat, and experience an abrupt drop in blood pressure. Blockages in the bile ducts may also be caused by other obstructions, including, but not limited to, tumors, inflammation due to trauma or illness, such as pancreatitis, infection, improper opening of sphincter valves, lesions and/or scarring within the ducts, and/or pseudocysts (accumulations of fluid and tissue debris).

Complications from blockages within the bile ducts can very serious, and include infection of the common bile duct 108 (cholangitis) and inflammation of the pancreas 114 (pancreatitis) and potentially lead to death. Accordingly, it is important to address such a blockage so as to restore adequate drainage through the affected duct. In some cases, the obstruction may not be amenable to a surgical cure or bypass, and, instead, requires a palliative drainage procedure. A palliative drainage procedure is designed to prolong the life of the patient and to make the patient more comfortable when the condition of the patient is incurable.

In cases where a patient may have a biliary obstruction, Endoscopic Retrograde Cholangiopancreatography (ERCP) has been used by clinicians as the standard procedure to perform palliative biliary drainage over the more invasive Percutaneous Transhepatic Biliary Drainage (“PTBD”) approach. The ERCP approach is an endoscopic procedure that combines upper gastrointestinal (GI) endoscopy and x-rays to treat problems of the bile and pancreatic ducts. For example, as shown in FIG. 3, during an ERCP procedure, an endoscope 122 is inserted into a patient's mouth, down the esophagus, into the stomach, passing into the lumen of the duodenum 120 to a position adjacent the ampulla of Vater 118. The endoscope 122 provides the initial access and direct visualization of the general area of treatment.

The endoscope 122 generally includes a proximal end (not shown), a distal end 124, and at least one lumen extending the length thereof. The distal end 124 of endoscope 120 generally includes a side opening in fluid communication with the lumen, such that additional medical devices may emerge from endoscope 122 from this side opening. It is these additional medical devices, which pass through endoscope 122, which are used to navigate and treat the abnormal pathologies within the desired duct. In particular, a biliary catheter 126 is advanced through endoscope 122 until the distal tip of biliary catheter 126 emerges from the endoscope 122 side opening and is advanced to the ampulla of Vater 118 leading to the common bile duct 108 and the pancreatic duct 112.

A guidewire (not shown) may be used in conjunction with biliary catheter 126 to aid in accessing a desired location within the biliary tree 128. For example, the guidewire is inserted in an opening at a proximal end of biliary catheter 126 and guided through the catheter lumen until it emerges from the distal end of the biliary catheter 126. The biliary catheter 126 is then advanced over the guidewire until the distal end of the catheter is positioned in the biliary tree 128 at the desired location. The biliary catheter 126 is now in a position for delivery of contrast media within the desired duct, wherein the contrast media allows for fluoroscopic visualization of anatomical detail within the biliary tree 128. The fluoroscopic visualization may reveal abnormalities and/or blockages within the common bile duct 108 that may require treatment, such as biliary drainage.

While ERCP enjoys a high success rate, biliary cannulation fails in approximately 5 to 20% of cases. For example, cannulation of the ampulla of Vater can be a daunting task for the clinician. In order to gain access to the ducts, the clinician must gently press the tip of the biliary catheter, or guidewire, into and through the opening of the ampulla of Vater. However, despite the best efforts of the clinician, cannulation of the ampulla of Vater will not occur through traditional “push-pull” techniques due to endoscopist inexperience, a distorted anatomy of the ampulla of Vater due to tumor invasion of the duodenum or ampulla, surgically altered anatomy, and/or complex biliary structures. In these instances, a clinician may probe the ampulla for an extended period of time with little success. Prolonged probing may further cause inflammation of the ampulla, wherein each attempt at cannulation increases trauma to the surrounding tissue, and subsequently, increases the discomfort experienced by the patient.

Advancements in the field of gastrointestinal endoscopy have provided clinicians with the ability to perform Endoscopic Ultrasound Guided Biliary Drainage (EUS-BD) in cases where traditional ERCP has failed or may not be administered. In particular, Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) has been used to cannulate a biliary duct via an EUS/ERCP rendezvous technique. For example, as shown in FIG. 4, under a rendezvous technique, a clinician may advance an EUS endoscope 122 into the lumen of a patient's duodenum 120 to a position in which bile ducts may be visualized (e.g., via endosonography). The clinician may then advance an FNA needle 130 into the common bile duct 108 under EUS guidance by puncturing trans-duodenally, as indicated by arrow 132. After confirmation of bile duct puncture, a guidewire 134 may then be advanced distally through the bile duct 108 and across the ampulla of Vater 118. When the guide wire has passed through the ampulla into the duodenum 120, an endoscope exchange is performed, wherein the EUS scope 122 is withdrawn, leaving the guidewire 134 in place, and a side-viewing endoscope (e.g., duodenoscope) is then passed into the duodenum 120 adjacent the EUS-placed guidewire 134. The guidewire 134 is then grasped with a snare or forceps for subsequent over-the-wire cannulation (e.g., via biliary catheter), upon which access to the common bile duct 108 is achieved and a standard ERCP procedure can then be performed (e.g., open blocked ducts, break up or remove gallstones, remove tumors in the ducts, insert stents, and/or endoscopic sphincterotomy). It should be noted that, in other EUS/ERCP rendezvous procedures, access to the common bile duct 108 is not limited to trans-duodenal access, as illustrated in FIG. 4. For example, access to the common bile duct 108 may be achieved trans-gastrically, such that the FNA needle 130 is advanced through the gastric wall of the stomach and into the common bile duct 108 under EUS guidance.

The EUS/ERCP rendezvous technique may be a preferred approach for many endoscopists because of the less invasive nature it provides, particularly for biliary drainage. However, this approach may have many drawbacks. For example, the rendezvous technique generally requires significant skill on behalf of the clinician due to a lack of currently available tools designed specifically for successful guidewire tracking. Specifically, current needle designs are rigid, thereby severely limiting the clinician's ability to direct the guidewire. Furthermore, biliary drainage via the rendezvous technique may not be possible if the guidewire is unable to be advanced through the ampulla because of difficult angulation or a tight distal biliary stricture. Accordingly, biliary drainage by needle rendezvous technique may require repeat punctures with different angles often resulting in a prolonged, labor-intensive procedure with the risk of shearing the guidewire and/or biliary leakage. Further difficulties currently observed by clinicians performing the EUS/ERCP rendezvous technique are difficulties advancing or directing the guidewire across an obstruction, difficulty achieving penetration into the biliary duct, clinical complications, such as pancreatitis, due to ductal trauma. Furthermore, the required scope exchange between EUS endoscope and an ERCP scope for guidewire retrieval can be cumbersome and plagued with difficulties.

SUMMARY

The present disclosure provides an endoscopic ultrasound (EUS)-guided access system having a maneuverable catheter assembly configured for providing access to and navigating a desired vessel for subsequent treatment thereof. In embodiments described herein, the access system is configured for providing access to one or more tissues/organs associated with the pancreaticobiliary system for the purpose of providing treatment. In particular, the access system described herein is configured to provide access to at least the common biliary duct via an Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) technique and to further allow procedures to treat narrowed areas or blockages within the bile duct, including palliative drainage procedures. Accordingly, the access system is configured to provide Endoscopic Ultrasound Guided Biliary Drainage (EUS-BD). However, it should be noted that the access system of the present invention is not limited to the pancreaticobiliary system. The access system of the present invention can be used to provide access to a variety of different systems of the human body, particularly where maneuverability and accuracy is desirable.

The access system of the present invention includes an adjustable delivery handle assembly and an access catheter subassembly configured to be delivered to a desired site and to further gain access to the site. The access catheter subassembly includes an access catheter having at least a distal section having an adjustable portion along a length thereof configured to transition to a pre-defined arcuate shape, particularly once deployed into a desired site, such as the common biliary duct. The pre-defined arcuate shape is configured to provide a clinician with directional control over the distal end of the catheter as it is navigated through the duct, wherein the internal anatomy of the duct may be complicated and narrow. In some embodiments, the access catheter may further include one or more cutting elements, such as a dielectric cautery ring and/or cutting knife configured to allow the clinician to ablate/cut through tissue so as to widen an obstructed pathway and/or completely remove a tumor or other obstruction (e.g., gallstone). Additionally, or alternatively, the access catheter may also have steerable functionality. For example, one or more control, or steering, wires may be positioned within and anchored to at least the distal section, such that a force applied to the one or more control wires results in manipulation of at least the distal end.

The handle assembly includes one or more elements configured to allow a clinician to maneuver and manipulate the distal end of the access catheter while navigating the vessel. In one embodiment, the handle assembly includes inner hub housing having a first plurality of radially-spaced barbs disposed on an inner diameter thereof and the access catheter subassembly further includes a catheter hub configured for insertion into the inner hub housing. The catheter hub has a second plurality of radially-spaced barbs disposed on an outer diameter thereof, wherein each of the second plurality of barbs are configured for selective engagement with a corresponding one of the first plurality of barbs to permit incremental rotation of the catheter hub relative to the inner hub housing. The access catheter is coupled to the catheter hub, such that, the distal section of the access catheter is configured to incrementally rotate about a longitudinal axis defined by the lumen of the catheter body in conjunction with incremental rotation of the catheter hub. Upon a clinician removing rotational force, engagement between the first and second barbs ensures that the distal section, particularly the adjustable portion, remains fixed the desired location and does not whip. As such, a clinician may remove their grip from the handle assembly, while the position of the distal section is maintained.

Accordingly, the access system of the present invention provides a clinician with the ability manipulate the adjustable portion of the distal section, particularly when the adjustable portion is in the pre-defined arcuate shape, thereby providing an increased overall range of motion to allow improved manipulation during navigation of a vessel. Thus, the access system of the present invention provides access to the appropriate vessel (e.g., biliary duct), allows manipulation of the catheter, as well as other tools (e.g., guidewire) into position so as to achieve trans-papillary placement (across the ampulla of Vater), and further achieve internal drainage of the biliary duct (e.g., via antegrade placement of a stent), all without having to perform a scope exchange (as current techniques require US scope to ERCP scope exchanges during rendezvous procedure for biliary duct drainage).

The access system of the present invention overcomes many of the drawbacks associated with the EUS/ERCP rendezvous technique. In particular, the pre-defined arcuate shape of the access catheter of the present invention provides improved initial access to the biliary duct, due in part to the initial trans-duodenal puncture, which occurs in a relatively orthogonal angle to the lumen of the biliary duct. Accordingly, upon initially accessing the biliary duct with the catheter, the pre-defined arcuate shape of the distal section results in the distal end of the catheter being aligned with the lumen of the biliary duct, such that guidewire advancement is improved and decreases the risk of injury to surrounding tissue when advancing a guidewire. Furthermore, the increased mobility of the access catheter, particularly the increased flexibility of the distal end, as well as improved manipulation of the distal end, not only in a rotational manner, but also in left, right, front, and back directions relative to the longitudinal axis of the catheter, improves the clinician's ability to navigate the lumen of the duct, and further advance past obstructions that may have been otherwise impassable with conventional catheters used in EUS/ERCP rendezvous technique.

In certain aspects, the present disclosure provides a system for providing access to a vessel. The system includes an adjustable delivery handle system including a delivery handle assembly, at least a portion of which includes an inner lumen configured to receive one of a plurality of exchangeable subassemblies. The delivery handle subassembly further includes a sheath coupled to a distal end of the handle assembly and having a lumen in fluid communication with the inner lumen of the delivery handle assembly. The system further includes an access catheter subassembly removably disposed within the inner lumen of the delivery handle assembly and lumen of the sheath. The access catheter includes an access catheter having an elongate tubular body having a proximal section having a proximal end, a distal section having a distal end, an outer surface, and an inner surface defining a lumen extending from the proximal end to the distal end. The distal section includes an adjustable portion along a length thereof configured to transition between a pre-defined arcuate shape and a substantially linear shape.

In some embodiments, when disposed within the lumen of the sheath, the adjustable portion of the distal section of the access catheter is configured to maintain a substantially linear shape. Upon extension from the lumen of the sheath, the adjustable portion of the distal section of the access catheter is configured to transition to the pre-defined arcuate shape. When in the pre-defined arcuate shape, the adjustable portion forms at least one angle relative to a longitudinal axis defined by the lumen of the catheter body, wherein the at least one angle is between 0 and 170 degrees.

In some embodiments, the system further includes a stylette member removably disposed within the inner lumen of the delivery handle assembly, lumen of the sheath, and lumen of the access catheter. The stylette member has a distal end configured to pierce tissue of a vessel to provide access to an interior of the vessel. When the stylette member is disposed within lumen of the adjustable portion of the distal section of the access catheter, the adjustable portion is configured to maintain a substantially linear shape. Upon removal of the stylette member from within the lumen of the adjustable portion, the adjustable portion is configured to transition to the pre-defined arcuate shape.

In some embodiments, the proximal section and the distal section of the access catheter have different levels of stiffness. For example, the proximal section has a greater level of stiffness than the distal section.

In some embodiments, the distal section of the access catheter further includes a portion adjacent the distal end having enhanced echogenicity or acoustic reflection, which may be particularly helpful in locating the distal section via ultrasound techniques. In some embodiments, the distal section of the access catheter has a metallic distal tip at a distal end.

The metallic distal tip may provide sufficient durability and strength for allowing the distal end to puncture through relatively tough and/or fibrous tissue, in which the distal end would deflect from without the metallic distal tip. In some embodiments, the distal section of the access catheter includes a tubular body formed from densely packed tubular coil. An interior surface of the lumen of the distal section has a liner disposed thereon having a relatively low coefficient of friction. Such a coiled configuration is configured to enhance flexibility for access catheter advancement while also enhancing torque transmission during manipulation.

In some embodiments, the delivery handle assembly further includes an inner hub housing coupled thereto. The inner hub housing having a first plurality of radially-spaced barbs disposed on an inner diameter thereof. The access catheter subassembly further includes a catheter hub configured for insertion into the inner hub housing, the catheter hub having a second plurality of radially-spaced barbs disposed on an outer diameter thereof. Each of the second plurality of barbs is configured for selective engagement with a corresponding one of the first plurality of barbs to permit incremental rotation of the catheter hub relative to the inner hub housing. The proximal section of the access catheter is coupled to the catheter hub, such that the distal section of the access catheter is configured to incrementally rotate about a longitudinal axis defined by the lumen of the catheter body in conjunction with incremental rotation of the catheter hub.

In some embodiments, the access catheter further includes a cutting element positioned on the distal section adjacent to the distal end. The cutting element may include a cautery ring or a cutting knife, or the like. In some embodiments, the access catheter further includes at least one control element configured to cause movement of at least the distal end relative to a longitudinal axis defined by the lumen of the catheter body upon application of force thereto. For example, the distal section of the catheter may be steerable upon application of force (e.g., tension) on control wires.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates an overview of an exemplary biliary system.

FIG. 2 illustrates the biliary system of FIG. 1 with one or more obstructions in a biliary duct.

FIG. 3 illustrates the advancement of an endoscope through the duodenum to a position adjacent the ampulla of Vater;

FIG. 4 illustrates an endoscopic ultrasound guided rendezvous technique for achieving biliary drainage.

FIG. 5 is an assembly drawing depicting the present invention incorporating the delivery system handle, catheter sheath and aspiration needle for the intended field of use.

FIG. 6 is a drawing of the aspiration needle sub-assembly of the present invention.

FIG. 7 is a cross sectional drawing of the needle protector embodiment of the present invention shown in FIG. 6.

FIG. 8 is a cross sectional drawing of the proximal end of the aspiration needle sub-assembly shown in FIG. 6.

FIG. 8A is a drawing of an alternate preferred embodiment of the proximal end of the aspiration needle sub-assembly with strain relief.

FIG. 8B is a cross sectional drawing of the proximal end of the aspiration needle sub-assembly with strain relief.

FIGS. 9A through 9D depict various enlarged views of a thumb latchincluded in the proximal portion of the delivery system handle of the invention.

FIG. 9 is a cross sectional drawing of the delivery system handle of the present invention.

FIG. 10 is an enlarged view of encircled Portion A shown in FIG. 9, and depicts a cross sectional drawing of the needle locking mechanism of the delivery system handle of the present invention.

FIG. 11 is an enlarged view of encircled Portion B shown in FIG. 9, and depicts cross sectional drawing of the needle extension length adjustment mechanism of the delivery system handle of the present invention.

FIG. 12 is an enlarged view of encircled Portion C shown in FIG. 9, and depicts a cross sectional drawing of the catheter sheath extension length adjustment mechanism of the delivery system handle of the present invention.

FIG. 13 is an enlarged view of encircled Portion D shown in FIG. 9, and depicts a cross sectional drawing of the distal end of the assembled delivery system handle of the present invention, incorporating the mechanism for attachment to the endoscope.

FIGS. 14A through 14O depict exemplary embodiments of an echogenically enhanced region at the distal end of an aspiration needle for use in the devices of the invention.

FIG. 14 is a drawing of the distal end of the needle with mounted needle collet.

FIG. 15 is a drawing of the extreme distal end of the needle.

FIG. 16 is a drawing of the bevel detail of the needle of the present invention, incorporating primary angle, secondary angle, tertiary and back-cut angle elements.

FIG. 17 is a cross sectional drawing of the bevel detail of the needle of the present invention, illustrating the tertiary angle of the grind detail.

FIG. 18 is a cross sectional drawing of the proximal end of the needle protector hub sub-assembly.

FIG. 19 is a drawing of the intended functionality of the needle protector assembly.

FIG. 20 is a drawing of the intended functionality of the needle protector and aspiration needle assemblies during needle exchange and more specifically, during needle insertion.

FIG. 21 is a drawing of the intended functionality of the needle protector and aspiration needle assemblies during needle exchange and more specifically, during needle insertion and locking in the device handle.

FIG. 22 is a drawing of the locking functionality of the needle protector and aspiration needle sub-assemblies in the hub housing components of the device handle.

FIG. 23 is a cross-sectional drawing of locking functionality between the needle hub, thumb latch and hub housing components.

FIG. 24 is a drawing of the hub needle hub and hub housing with interlocking capability to ensure non-rotation.

FIG. 25 is an alternate embodiment of the present invention, to facilitate rotation between needle hub and hub housing components.

FIG. 26 is a drawing of the intended functionality of the present invention to withdraw the aspiration needle sub-assembly from the delivery system handle during needle exchange.

FIG. 27 is a drawing of the intended functionality of the needle collet during needle exchange and more specifically, during needle extraction from the device handle.

FIG. 28 is a drawing of the intended functionality of the needle collet during needle exchange and more specifically, during needle extraction from the device handle.

FIG. 29 is a drawing of the needle protector sub-assembly secured to the end of the aspiration needle, and the intended functionality of the needle sheath of the present invention.

FIG. 30 is a drawing of the distal end of the aspiration needle sub-assembly housed in the catheter sheath of the delivery system of the present invention.

FIG. 31 is a drawing of the distal end of the aspiration needle sub-assembly extending from the catheter sheath of the delivery system of the present invention.

FIG. 32 is a drawing of the intended functionality of the present invention, and more specifically of the intended functionality of the catheter sheath of the present invention.

FIG. 33 is a drawing of the construction of the catheter sheath component of the present invention.

FIG. 34 is a side view of an access catheter subassembly of the present invention.

FIG. 35 is a cross sectional view of the proximal end of the access catheter subassembly of FIG. 34.

FIG. 36 is a side view of a distal section of an access catheter of the present invention.

FIG. 37A is a side view, partly in section, of storage of the access catheter within the sheath of FIG. 34 including a stylette positioned within the access catheter.

FIG. 37B is a side view, partly in section, of extension of the access catheter and stylette of FIG. 37A from the sheath of FIG. 34.

FIG. 37C is a side view, partly in section, of withdrawal of the stylette from within a portion of the distal section of the access catheter.

FIG. 37D is a side view, partly in section, of further extension of the access catheter from the sheath of FIG. 34, illustrating the adjustable portion transitioning to a pre-defined arcuate shape.

FIG. 38 is a side view, partly in section, of the extended distal end of the access catheter illustrating manipulation of the distal end based on rotational movement of a catheter hub.

FIG. 39 is a perspective view of the inner hub housing of the delivery handle assembly and the catheter hub of the access catheter assembly.

FIG. 40 is a side view of another embodiment of a distal section of an access catheter of the present invention.

FIG. 41 is a side view of another embodiment of a distal section of an access catheter of the present invention.

FIG. 42 is a side view of another embodiment of a distal section of an access catheter of the present invention.

FIG. 43 is a cross sectional view of a portion of the distal section of the access catheter of FIG. 42.

FIG. 44 is a side view of another embodiment of a distal section of an access catheter of the present invention.

DETAILED DESCRIPTION

By way of overview, the present disclosure is generally directed to an access system having a maneuverable catheter assembly configured for providing access to and navigating a desired vessel for subsequent treatment thereof. In embodiments described herein, the access system is guided via endoscopic ultrasound (EUS) and configured for to provide access to one or more tissues/organs associated with the pancreaticobiliary system for the purpose of providing treatment. In particular, the access system described herein is configured to provide access to at least the common biliary duct via an Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) technique and to further allow procedures to treat narrowed areas or blockages within the bile duct, including palliative drainage procedures. Accordingly, the access system is configured to provide Endoscopic Ultrasound Guided Biliary Drainage (EUS-BD). However, it should be noted that the access system of the present invention is not limited to the pancreaticobiliary system. The access system of the present invention can be used to provide access to a variety of different systems of the human body, particularly where maneuverability and accuracy is desirable.

Embodiments of the present disclosure are now described in detail with reference to the drawings in which like reference numerals designate identical or corresponding elements in each of the several views. As used herein, the term “clinician” refers to a doctor, nurse or any other care provider and may include support personnel. Throughout this description, the term “proximal” will refer to the portion of the device or component thereof that is closer to the clinician and the term “distal” will refer to the portion of the device or component thereof that is farther from the clinician. Additionally, in the drawings and in the description that follows, terms such as front, rear, upper, lower, top, bottom, and similar directional terms are used simply for convenience of description and are not intended to limit the disclosure. In the following description, well-known functions or constructions are not described in detail to avoid obscuring the present disclosure in unnecessary detail.

The access catheter assembly of the present disclosure may be used in conjunction with minimally-invasive procedures, such as endoscopic biopsy procedures. For example, the access catheter may be compatible with an endoscopic biopsy device, such as needle biopsy delivery device configured for endoscopic ultrasound procedures. For example, the access catheter may be compatible for use with exemplary endoscopic delivery systems and methods discussed in Needle Biopsy Device with Exchangeable Needle and Integrated Needle Protection, U.S. Pub. 2012/0116248, Rapid Exchange FNA Biopsy Device with Diagnostic and Therapeutic Capabilities, U.S. Pub. 2011/0190662, Device for Needle Biopsy with Integrated Needle Protection, U.S. Pub. 2010/0121218, and Needle Biopsy Device, U.S. Pub. 2010/0081965, the contents of each of which are hereby incorporated by reference in their entirety.

An exemplary embodiment of an endoscopic delivery device for use with an access catheter of the present disclosure is illustrated in FIG. 5. The device design consists of a handle mechanism (delivery system handle 10) and aspiration needle sub-assembly 15. The delivery system handle 10 includes a proximal handle member 10a, a middle handle member 10b, and a distal handle member 10c. The proximal, middle and distal handle members each include an inner lumen and are coupled together to define a longitudinal axis such that the inner lumens are in constant communication and extends throughout the length of the coupled handle members. Proximal handle member 10a is slideably disposed over at least a portion of the middle handle member 10b, and middle handle member 10b is slideably disposed over at least a portion of distal handle member 10c. The proximal handle member 10a includes proximal handle grip 10a1 a distal handle grip 10a2. The delivery handle system 10 further includes an inner handle member 10d disposed within the inner lumen of the middle handle member 10b (shown in FIGS. 9 and 11). The delivery system handle 10 also incorporates a catheter sheath 14 component coupled to the distal end of the distal handle member 10c. This component provides a conduit between the delivery system handle 10 and the target sampling site during the exchange of aspiration needles. The device design is modular in that the aspiration needle sub-assembly 15 can be detached from the proximal handle member 10a of the device for each individual “pass” or aspirated sample taken by the endoscopist at the site of the lesion or abnormality.

The delivery system handle 10 incorporates two length adjustment features actuated via adjustment of two thumbscrew locking mechanisms. A threaded proximal thumbscrew 12 and locking ring 33 are moveably disposed around the middle handle member 10b; the proximal thumbscrew 12 is loosened to loosen locking ring 33, locking ring 33 is moved distally along the middle handle member 10b and tightened in the desired position along middle handle member 10b via proximal thumbscrew 12 to allow the user to establish a set depth of needle penetration beyond the end of the catheter sheath 14. A threaded distal thumbscrew 13 is transversely disposed at the distal portion of the middle handle member 10b; the distal thumbscrew 13 is loosened to move the middle handle member 10b distally and/or proximally and tightened to allow the user to establish a set depth of catheter sheath 14 extension beyond the end of the endoscope.

The aspiration needle sub-assembly 15 consists of the needle shaft 21 (which can range in length from 500 mm up to 2500 mm, but which more preferably ranges in length between 1640 mm to 1680 mm) and is beveled at the distal needle end to enhance tissue penetration during sample acquisition; needle hub 17; needle luer 18; needle collet 19; needle protection sub-assembly 9; stylette hub 20 and stylette shaft 22. The needle component itself can be manufactured from a number of metallic based (Stainless steel or alloys thereof; Nitinol or Alloys thereof etc. . . . ) or Polymeric Based materials including, but not limited to Poly-ether-ether ketone, Polyamide, Poyethersulfone, Polyurethane, Ether block amide copolymers, Polyacetal, Polytetrafluoroethylene and/or derivatives thereof).

FIG. 6 illustrates the aspiration needle sub-assembly 15 of the present invention. This sub-assembly is inserted into and removed from the lumen of the delivery system handle 10 in acquiring tissue samples. The aspiration needle sub-assembly 15 consists of a stylette hub 20 and stylette shaft 22 components which are securely locked on the needle luer 18 of the aspiration needle via conventional internal luer threads. The stylette hub 20 may be attached to the stylette shaft 22 via a number of processing techniques such as adhesive bonding or insert injection molding. The female luer of the aspiration needle incorporates a mating luer thread detail, onto which the stylette hub 20 may be tightened. The needle luer 18 element of the present invention may be attached to the proximal end of the needle shaft via a number of processing techniques such as adhesive bonding or insert injection molding.

The aspiration needle sub-assembly 15 also incorporates a needle collet 19 (previously described as “needle protrusion(s) and shown in FIGS. 7 and 14 of Applicant's co-pending application (U.S. Ser. No. 12/243,367, published as US2010/0081965). The function of this needle collet 19 is to (1) provide a means to center the needle shaft component in the catheter sheath of the delivery system during needle exchange (2) provide a mechanism or securing and locking the needle protector sub-assembly to the distal end of the aspiration needle once the needle has been unlocked and withdrawn from the delivery system handle. The needle collet 19 of the present invention may be attached to the distal end of the needle shaft 21 via a number of processing techniques such as adhesive bonding, laser welding, resistance welding, or insert injection molding. The needle collet 19 may be fabricated from metals materials such as stainless steel, nickel titanium or alloys thereof or polymer materials such as, but not limited to, Polyacetal, polyamide, poly-ether-block-amide, polystyrene, Acrylonitrile butadiene styrene or derivatives thereof. The needle collet 19 is located at a set point distance from the extreme distal end of the beveled needle. The distance from the extreme distal end of the needle bevel to the proximal collet position on the needle may be within the range of 6 cm to 12 cm but is more preferably in the range of 7 cm to 9 cm and more preferably is located 8 cm from the end of the needle. This ensures that when the needle is extended to a maximum extension distance relative to the distal end of the catheter sheath (i.e. 8 cm), the needle collet 19 does not exit the end of catheter sheath 14.

FIGS. 7 and 18 illustrate the needle protection sub-assembly 9 design embodiment of the current invention, in the locked position at the distal end of the needle. The needle protection sub-assembly 9 consists of two needle protector (NP) hub halves (collectively 23), which are adhesively bonded to each other, on the proximal end of the needle protector (NP) needle protector sheath 24. Alternately, these needle protector hub halves 23 may be snap fit together or may be insert injection molded over the needle protector sheath 24 to provide a secure bond/attachment between these components in the assembly. The needle protection sub-assembly 9 also incorporates a needle protector (NP) hub O-ring 25. This component resides in a recessed cut-out in the center of the assembled needle protector hub halves 23. This NP hub O-ring 25, in conjunction with the needle collet 19 which is securely attached to the distal end of the needle shaft 21 of the needle protection sub-assembly 9, provides a mechanism for locking the needle protection sub-assembly 9 onto the end of the needle. In this way, the bevel of the needle is protected, covered and shielded once the needle has been removed from the delivery system handle. It is desired that the needle protector sheath 24 of the present invention be manufactured from a translucent polymer such as, but not limited to polyurethane, polyamide and derivatives thereof.

The needle hub 17 embodiment of the aspiration needle sub-assembly as shown in FIG. 6 and FIG. 8 of the present invention, provides a mechanism which (1) locks the aspiration needle sub-assembly 15 into the delivery system handle 10 by means of the inner hub housing 27 and thumb latch 28 components (as will be described later in this disclosure) and (2) provides a means to lock the needle protection sub-assembly 9 embodiment shown in FIG. 7, into the delivery system device handle 10, as will be described later. As shown in FIG. 8, the needle hub 17 is securely attached to the needle luer 18 and needle shaft 21 components of the aspiration needle sub-assembly 15. The needle hub 17 of the present invention may be attached to the distal end of the needle luer 18 via a number of processing techniques such as adhesive bonding or insert injection molding.

An alternate preferred embodiment of the proximal end of the aspiration needle sub-assembly 15 is shown in FIGS. 8A and 8B. This embodiment incorporates a strain relief component 26, which extends from the distal end of the needle luer 18, through the body of the needle hub 17, to extend beyond the distal end of the needle hub 17. This tubular strain relief component 26 is intended to provide a more gradual stiffness transition between the needle hub 17 and needle shaft 21 components, particularly in the case of smaller needle gauge sizes (such as 22 AWG and 25 AWG). This strain relief component 26 may range in length from 10 mm to 50 mm but is more preferably in the range of 25 mm to 35 mm. The diameter of this strain relief component 26 must be sufficiently small so that it fits through the proximal end of the needle protection sub-assembly 9 (as shown in FIG. 7) and does not impair the ability for the needle protection sub-assembly 9 to slide back and forth on same. This strain relief component 26 may range in outer diameter from 0.020 inches to 0.060 inches but is more preferably in the range of 0.026 inches to 0.045 inches. This tubular strain relief component 26 may be fabricated from metal based materials, such as but not limited to stainless steel, nickel titanium or alloys thereof or polymer materials such as, but not limited to, Polyacetal, polyamide, poly-ether-block-amide, polystyrene, Acrylonitrile butadiene styrene or derivatives thereof.

FIG. 9 is a sectional view of the delivery system handle 10 for the present invention, without the aspiration needle sub-assembly 15 loaded therein. FIG. 10 (Detail A from FIG. 9) illustrates a sectional view of the proximal end 10a of the assembled device handle. This proximal portion of the handle (also shown in FIG. 20 and FIG. 22) contains elements to ensure secure, yet releasable locking of the aspiration needle sub-assembly 15 in the delivery system handle 10. The inner hub housing 27 is secured to the proximal delivery system handle halves 10a via adhesive bonding or ultrasonic welding techniques. The thumb latch 28 is securely locked into the inner hub housing 27 via a one-way keying action. Once the thumb latch 28 is inserted into the inner hub housing 27, the thumb latch 28 cannot be disassembled and may only be moved in the transverse direction to actuate the assembled mechanism.

FIGS. 9A, 9B, 9C, and 9D depict various views of an exemplary embodiment of the thumb latch 28 of the delivery system handle 10. The thumb latch 28 represents a mechanism to releasably lock the needle hub 17 of aspiration needle sub-assembly 15 within the inner hub housing 27 of the proximal handle member 10a of the delivery device. Thumb latch 28 may be, for example, a push-button, that activates the use of a deflectable hinge member 28a to provide for a return to the “home” position once external force is not applied to release thumb latch 28. Deflectable hinge member 28a can elastically deform to provide for the opening and closing of the “lock” during removal of the aspiration needle sub-assembly 15 from the delivery system handle 10. In one embodiment, thumb latch 28 incorporates an external coupler housing 28b and a push button design mechanism. FIGS. 9C and 9D illustrate thumb latch 28 in the CLOSED and OPEN positions during a typical actuation cycle.

Referring to FIGS. 9A and 9B, thumb latch 28 and external coupler housing 28b may be manufactured from a range of rigid, non-deformable, thermoplastic or thermoset materials such as, acrylonitrile butadiene styrene (ABS), styrene acrylonitrile (SAN), polystyrene or rigid derivatives thereof, polyamide, polyethylene, polyurethane, and polycarbonate. In an embodiment, the materials of manufacture have a durometer in the range of 35-120 Shore D, but more preferably in the range of 80-110 Shore D.

Deflectable hinge member 28a may be manufactured from a range of rigid, thermoplastic or thermoset materials such as, acrylonitrile butadiene styrene (ABS), styrene acrylonitrile (SAN), polystyrene or rigid derivatives thereof, polyamide, polyethylene, polyurethane, and polycarbonate. In an embodiment, the materials of manufacture shall be capable of deformation in bending under the application of an applied load, such as is encountered during a typical “Open and Close” cycle for the needle biopsy device without crazing, fatigue or cracking.

The proximal portion of the proximal handle member 10a of the delivery system handle 10, incorporates a retention collar 29 and a retention collar O-ring component 30. The retention collar 29 resides in a cut out nest in the proximal handle half, and is in communication with inner hub housing 27. The retention collar 29 is a cylindrical component, which is internally tapered and recessed to provide an internal, recessed shelf. The retention collar O-ring component 30 resides in this recessed shelf and is secured in position through the assembly of both halves of the delivery system handle halves. The purpose of this retention collar O-ring component 30 is to provide a method to lock and maintain the needle protector hub sub-assembly 9 of the aspiration needle sub-assembly 15, securely in the handle 10 of the delivery system while the tissue sample site is being accessed by the clinician, as described in detail below. The functionality and operation of this retention collar O-ring component 30 is the same as described in FIGS. 41 and 42 and associated abstract of the specification of Applicant's patent application U.S. Ser. No. 12/607,636 (published as US2010/0121218).

As shown in FIG. 10, the delivery system handle assembly 10 of the present invention incorporates an inner hypotube component 31. It is the design intent of this component to provide a conduit between the proximal handle member 10a of the delivery system, and the outer hypotube component 32 shown in FIG. 11. The inner hypotube component 31 may be fabricated from metal based materials, such as but not limited to stainless steel, nickel titanium or alloys thereof or polymer materials such as, but not limited to, Polyacetal, polyamide, poly-ether-block-amide, polystyrene, Acrylonitrile butadiene styrene or derivatives thereof. The inner hypotube component 31 is secured to the assembled handle halves of the device via adhesive bonding or insert injection molding techniques. During needle advancement, the proximal handle member 10a of the delivery system is distally advanced, in order to advance the distal end of the needle into the desired tissue sampling site. When the proximal handle member 10a is distally advanced, the inner hypotube component 31 is also advanced in unison in a distal direction. The inner hypotube component 31 is in constant longitudinal communication with the outer hypotube component 32 and is designed to telescope inside the outer hypotube component 32 at all times. This ensures that needle passage during needle exchange into and out of the delivery system, is not impaired.

Referring now to FIG. 11 (Detail B from FIG. 9), a cross sectional view of the distal end of the proximal handle member 10a and the middle handle member 10b is illustrated. During a typical EUS FNA procedure, the locking ring 33 is loosened via proximal thumbscrew 12, moved distally and set to a pre-established depth by the clinician, dependent upon depth of needle penetration required. Once the locking ring 33 has been moved distally (via the proximal thumbscrew) and locked to the required depth of penetration, the proximal handle member 10a of the delivery system is advanced. During advancement, the proximal handle member 10a moves in a longitudinal direction over the middle handle member 10b and inner handle member 10d. The inner handle member 10d and middle handle member 10b components are securely bonded to each via adhesive bonding or ultrasonic welding techniques and remain in a stationary, locked position during needle advancement via proximal handle member 10a actuation in a distal direction.

As shown in FIG. 11, the outer hypotube component 32 is also in constant communication with the catheter sheath 14 of the delivery system. The proximal end of the catheter sheath 14 is flared in an outward direction. The distal end of the outer hypotube component 32 is inserted into flared end of the catheter sheath 14 and secured thereto via adhesive bonding or insert injection molding techniques. The inner handle member 10d is bonded to both the proximal end of the catheter sheath 14/outer hypotube component 32 assembly via adhesive bonding or insert injection molding techniques. In this way, the inner hypotube component 31, outer hypotube component 32 and catheter sheath 14 are in constant communication, ensuring for smooth needle passage during needle exchange. This design embodiment, also ensures that the catheter sheath 14 may be advanced through the distal handle member 10c as required.

FIGS. 12 and 13 illustrate the design assembly embodiments for catheter sheath extension length adjustment in the case of the present invention. Referring to FIG. 12, the distal end of the middle handle member 10b incorporates a threaded insert 7 and distal thumbscrew 13. The catheter sheath extension distance beyond the end of the endoscope may be adjusted by loosening the distal thumbscrew 13 and advancing the middle handle member 10b in a distal direction over the distal handle member 10c. The distal handle member 10c and middle handle member 10b are in constant longitudinal communication with each other.

Referring to FIG. 13, the distal end of the delivery system handle assembly 10 is illustrated. The distal handle member 10c is secured to a recess in the distal luer holder 6 via adhesive bonding or ultrasonic welding techniques. The distal luer holder 6 is securely attached to the scope luer lock 5 via adhesive bonding or insert injection molding techniques. The distal handle member 10c is designed in such a way that once the device handle is attached to the working channel port of the endoscope, the assembly cannot rotate independently of assembled scope luer lock 5 and distal luer holder 6 components. Once the entire delivery system handle 10 (as shown in FIG. 5 and cross sectional view FIG. 9) has been locked onto the endoscope via the scope luer lock 5, the catheter sheath length and needle penetration extension length may be established as previously described.

FIG. 14 is an illustration of the distal end of the aspiration needle of the present invention, with needle collet (referred to as “needle protrusions” in Applicant's patent application U.S. Ser. No. 12/607,636, published as US2010/0121218) secured on the needle. It is preferable that the length of this needle collet 19 be in the range of 2 mm to 10 mm, but more preferably in the range of 3.5 mm to 5 mm. It is preferable that the outer diameter of the needle collet 19 be in the range of 0.030 inches to 0.080 inches, but more preferably in the range of 0.040 inches to 0.070 inches. This needle collet 19 (see also FIG. 18 and FIG. 30) is also chamfered at the proximal and distal ends of same. It is preferable that the chamfer angle of the needle collet be in the range of 15 degrees to 80 degrees, but more preferably in the range of 30 degrees to 60 degrees. This chamfer on both ends of the needle collet 19 is intended to provide smooth locking and unlocking with the needle protector sub-assembly 9 during needle exchanges.

As depicted in FIG. 14, and FIGS. 14A through 14O, the distal end of the needle of the present invention incorporates an embodiment to enhance the echogenic signature of the needle. In the case of the present invention, this echogenically enhanced region 34 can be fabricated by, but not limited to roughening the end of the needle over a pre-defined length close to proximal end of the needle bevel 35. It is preferable that the length of this echogenically enhanced region 34 be in the range of 2 mm to 20 mm, but is more preferably in the range of 10 mm to 15 mm. In the case of the present invention, the echogenic enhanced pattern is imparted to the needle via a micro-blasting process which roughens the surface of the needle over a specific length, improving the visibility of the needle under endoscopic ultrasound.

In certain aspects of the invention, the echogenically enhanced region of the needle is achieved through the removal of material from the surface of the needle to provide greater reflectivity and strengthened reflected signal. It is contemplated that the removal of material does not, however, reduce the performance of the needle from a pushability perspective or deter its ability to acquire a desired sample.

Referring now to FIG. 14A, a perspective view of an embodiment of a needle 600 is presented. Needle 600 is comprised of a plurality of depressions 602. Depressions 602 may be, but are not limited to, circular, concave, cylindrical, helical, oval, rectangular, and square elements that take the form of indentations on the surface of needle 600. Depressions 602 may be arranged in a helical (spiral) fashion around the circumference of the distal needle end. These indentations may extend to the extreme end of the bevel or may end at a specific distance from the bevel of needle 600. The length of the distal end of needle 600 containing these depressions may be, for example, from one to twenty centimeters. In another embodiment, the length is between five to ten centimeters. Referring to FIGS. 14B and 14C, depression 602 have a concave detail 604. Referring to FIGS. 14D and 14E, depressions 602 have a square base edge 606. Referring to FIGS. 14F and 14G, depressions 602 have a hemispherical base detail 608.

Referring now to FIG. 14H, a perspective view of another embodiment of a needle 610 is presented. Needle 610 is comprised of elliptical depressions 612 around the circumference of the distal end of needle 610. Referring to FIG. 14I, a perspective view of an embodiment of a needle 614 having square depressions 616 is presented. Depressions 616 may extend to the extreme end of the bevel or may end at a specific distance from the bevel of needle 614. Referring to FIGS. 14J and 14K, embodiments of needle 614 including spiral depressions 620 and helical depressions 622 are presented. Referring to FIG. 14L, a depression 624 has a concave detail. Referring to FIG. 14M, a depression 626 has a square base edge. Referring to FIG. 14N, a depression 628 has a hemispherical base detail.

Referring now to FIG. 14O, a diagram of ultrasound waves impinging upon a needle depression at angles of α1630 and β1632 respectively are presented. In an embodiment, a wave strikes the base of the depression and is reflected upwards at angle of reflection of α2634 and β2636 respectively, which are equal to the angles of incidence of α1630 and β1632 respectively. This reflected beam is reflected a second time off the adjacent wall of the depression at an angle of reflection of α3638 and β3640 respectively, which are equal to the angles of incidence, α1630 and β1632 respectively and the angles of first reflection α2634 and β2636 respectively. In this manner, the reflected wave becomes reflected along the same angle of incidence as the initially propagated incident beam back to the transducer of the ultrasound device. In an embodiment, a square edge depression design may provide for more efficient remittance of ultrasound waves during the procedure.

FIGS. 15 and 16 are drawings of the distal end of the needle of the current invention. The distal end of the needle bevel 35 of the current invention is beveled to enhance the ability of the needle to penetrate tissue during sample acquisition. The needle bevel 35 of the present invention incorporates four angular bevel grinds, which, in addition to enhancing tissue penetration, also ensure the smooth passage of the needle down the catheter sheath of the delivery system during needle exchange. Referring to FIG. 16, the needle bevel grind of the current embodiment incorporates a primary angle (“A”), a secondary angle (“B”), a back-cut angle (“C”) and tertiary angles (“D”), as shown in FIG. 17. It is preferable that the primary angle be in the range of 10 degrees to 25 degrees, but more preferably in the range of 12 degrees to 18 degrees. It is preferable that the secondary angle be in the range of 15 degrees to 35 degrees, but more preferably in the range of 22 degrees to 28 degrees. It is preferable that the tertiary angle be in the range of 15 degrees to 35 degrees, but more preferably in the range of 22 degrees to 28 degrees. It is preferable that the back-cut angle be in the range of 15 degrees to 70 degrees, but more preferably in the range of 25 degrees to 45 degrees.

During needle exchange, it is important that the aspiration needle (with pre-loaded stylette 2) can be passed through the internal diameter of the catheter sheath 14 without catching on the internal wall of same. In order to achieve this, the bevel grind of the current invention incorporates a back-cut grind detail. This back-cut detail acts as a “bumper” during needle passage through the sheath. As the needle advances, the heel of the back-cut comes in contact with the internal diameter of the sheath and reduces the friction between needle bevel 35 and catheter sheath 14 components. In this way, the needle can be smoothly tracked through the catheter sheath to exit the end of the catheter sheath 14.

FIG. 18 and FIG. 19 illustrate the method of engagement and disengagement between the aspiration needle sub-assembly 15 with mounted needle collet 19 and the needle protector (“NP”) sub-assembly 9. Referring to FIG. 18, the needle protector hub 23 is locked onto the needle collet 19 at the distal end of the needle shaft 21 by inserting the needle shaft 21 into the needle protector hub 23. As the needle/NP protector assembly is inserted into the handle of the delivery system, the needle shaft 21 and needle collet 19 are advanced such that the needle collet 19 traverses the deformable NP Hub O-ring 25. The internal diameter of the NP Hub O-ring 25 in the non-deformed state, is smaller than the outer diameter of the needle collet 19. Due to the soft durometer and elastic nature of the NP Hub O-ring 25, as the needle shaft 21 and attached needle collet 19 are moved distally, the NP hub O-ring 25 deforms allowing the collet to traverse the NP hub O-ring 25 under applied longitudinal force. Once the needle collet 19 has traversed the NP hub O-ring 25, the needle shaft 21 with pre-mounted needle collet 19 are tracked through the catheter sheath 14 to the intended target site. This aspect of the current invention is also illustrated in FIG. 27.

FIGS. 20, 21, and 22 illustrate the mechanism by which the aspiration needle sub-assembly 15 is locked into the handle 10 of the delivery system. First, the aspiration needle sub-assembly 15 is pre-mounted with needle protection sub-assembly 9, as previously described. As shown in FIG. 20, at the start of a needle insertion cycle, the aspiration needle/protection assembly is inserted into the proximal handle member 10a of the delivery system handle 10. As the needle/protection assembly is advanced, the needle protector hub 23 contacts the retention collar O-ring component 30. Under application of additional force (as illustrated per FIGS. 18 and 19) the needle collet 19 traverses the internal NP Hub O-ring 25 and advances distally down the catheter sheath 14, as described above. As the needle hub 17 component is advanced into the inner hub housing 27 of the proximal handle member 10a, the distal end of the needle hub 17, contacts the proximal end of the NP sub-assembly 9. Continually inserting the needle hub 17, pushes the NP sub-assembly 9 forward so that the needle protector hub 23 traverses the deformable retention collar O-ring component 30 until it comes to rest. At this juncture, the needle protector hub 23 and sub-assembly 9 are locked in position within the proximal handle member 10a and do not move. Simultaneously, the needle hub 17 deflects the thumb latch 28. Once the NP sub-assembly 9 has traversed the retention collar O-ring component 30 (as shown in FIG. 22), the needle hub 17 is securely locked into the inner hub housing 27 by traversing an internal land ring 36 on the needle hub 17, as shown in Detail F of FIG. 23.

FIG. 23 illustrates a sectional view of the aspiration needle locked into the thumb latch 28/inner hub housing 27 components of the delivery system handle 10. As the needle hub 17 is advanced into the inner hub housing 27 in the handle, the needle hub 17 contacts the internal taper of the thumb latch 28 at the thumb latch distal end. This causes the thumb latch 28 distal end to move laterally and also causing the deflectable hinge member 28a of the thumb latch 28 (see FIG. 26 also) to deform under plastic deformation, against the hub housing barb 37. Once the needle hub 17 is completely advanced into the inner hub housing 27, the distal end portion of the thumb latch 28, returns to the home position. The interference between the internal land ring 36 on the needle hub 17 and the thumb latch distal end, ensures that the needle hub 17 will not move backwards.

An intended functionality of thumb latch 28 is to prevent the aspiration needle subassembly 15 from being removed from the proximal handle member 10a without applying force to release thumb latch 28. As shown in FIG. 26, the aspiration needle may be exchanged or withdrawn from the delivery system handle 10 by depressing the thumb latch 28 and withdrawing the needle hub 17 from the inner hub housing 27. As the thumb latch 28 is depressed, the deflectable hinge member 28a of the thumb latch 28 contacts the hub housing barb 37. The thumb latch 28 moves in a lateral direction. This action clears the interference between the internal land ring 36 and distal end of the thumb latch 28. In this way, the aspiration needle can be removed un-impaired from the delivery system handle. Additionally, follow-up samples may be acquired using the same or a virgin aspiration needle sub-assembly.

FIG. 24 illustrates the preferred embodiments of the inner hub housing 27 and needle hub 17 embodiments of the present invention. In this instance, the inner hub housing 27 contains depressed female détentes 40 on the inner diameter of the inner hub housing 27. These détentes 40 are equispaced around the internal circumference of the hub housing body. It is preferable that the number of détente features be in the range of 2 to 15, but more preferably in the range of 6 to 10. These détente features provide a mechanical lock with corresponding interlocking barbs 41 on the external surface of the needle hub 17. Once the needle hub 17 is securely locked in the inner hub housing 27 in the device handle, the interlocking barbs 41 on the needle hub 17 become seated in the détentes 40 of the hub housing. This mechanical lock prevents the needle hub 17 from rotating relative to the inner hub housing 27 and delivery system handle 10, during a typical endoscopic ultrasound procedure. Alternatively, the inner surface of the inner hub housing 27 can be a smooth inner surface 27a. Likewise, the external surface of the needle hub 17 is smooth external surface 17a, to allow the needle hub 17 to rotate relative to the inner hub housing 27 and delivery handle system 10 during an endoscopic ultrasound procedures (FIG. 25).

During aspiration needle exchange, and more specifically during needle insertion, the needle collet 19 disengages from the NP Hub O-ring 25 by traversing the NP Hub O-ring 25 as explained above. FIGS. 27 and 28 illustrate the engagement of the needle collet 19 with the needle protector sub-assembly 9 upon needle extraction post sample acquisition. As the aspiration needle is continually withdrawn from the delivery system handle 10, the needle collet 19 contacts the NP hub O-ring 25 as shown in FIG. 27. As the aspiration needle is continually withdrawn, the needle collet 19 traverses the NP hub O-ring 25 as shown in FIG. 28. As the needle is further withdrawn, the needle protector hub 23 traverses the retention collar O-ring component 30 and the needle can be completely removed from the system, with the needle protector sub-assembly 9 encasing the distal bevel of the needle bevel 35 to prevent inadvertent “needle sticking”, as illustrated in FIG. 29 and Detail G.

In the case of the present invention, the needle protector sheath 24 is internally tapered 24a at the distal end (FIG. 29). It is preferable that length of this internal taper be in the range of 1 mm to 10 mm but more preferably in the range of 3 mm to 6 mm. It is also preferable that the internal taper angle on the distal end of the needle protector sheath be in the range of 2 degrees to 30 degrees, but more preferably in the range of 5 degrees to 15 degrees.

FIG. 30 is an illustration of the distal end 14a of the catheter sheath 14 of the delivery system (not shown) with aspiration needle loaded in the device handle, with the device handle in the fully retracted position. In this instance, the distal end of the needle lies proximal to the distal tapered end 14a of the catheter sheath 14. FIG. 31 illustrates the position of the needle shaft 21 and needle collet 19 relative the catheter sheath 14 when the needle is in a fully extended position. In the fully extended position, the needle collet 19 remains housed inside catheter sheath 14, proximal to the tapered distal tip.

In the case of the present invention, the catheter sheath 14 is manufactured from a thermoplastic polymer such as, but not limited to Polyurethane, Polyamide and derivatives thereof, Ether block amide copolymers, Polyimide, Placental, Polyethylene and derivatives thereof, polytetrafluoroethylene. The preferred embodiment of the catheter sheath 14 (as shown in FIG. 33) is that the catheter sheath 14 incorporates a helically braided reinforcing structure 45 housed between inner 46a and outer polymer 46b layers, of outer thermoplastic material such as those mentioned above with a lubricious inner liner or core. In the case of the present invention, the helically braided reinforcing structure 45 is fabricated from stainless steel wire. It is preferable that the diameter of this reinforcing braid wire be in the range of 0.0005 inches to 0.010 inches but more preferably in the range of 0.0015 inches to 0.005 inches It is preferable that the outer diameter of the catheter sheath 14 be in the range of 0.050 inches to 0.140 inches but more preferably in the range of 0.085 inches to 0.0105 inches. It is preferable that the inner diameter of the catheter sheath 14 be in the range of 0.050 inches to 0.120 inches but more preferably in the range of 0.065 inches to 0.085 inches.

In the case of the present invention (and as illustrated in FIGS. 30 and 31), it is preferable that the distal end 14a of the catheter sheath 14 be tapered to reduce both the outer diameter and the internal diameter of the catheter sheath tip. This taper may be imparted to the distal end of the catheter sheath 14 via swaging or thermal heat forming techniques. It is preferable that the inner diameter of the catheter sheath 14 be tapered at the distal end 14a to an internal diameter in the range of 0.020 inches to 0.060 inches but more preferably in the range of 0.040 inches to 0.050 inches.

Referring now to FIG. 32, An aspect of the present invention which provides the clinician with improved procedural performance over prior art devices, concerns the ability of the tapered catheter sheath 14 of the present invention to keep the aspiration needle of the device centered in the working channel conduit of the endoscope. Due to the increased outer diameter of the catheter sheath 14 of the present invention (in the range of 6.5 French to 8 French) compared to that of the prior art (approximately 5 French to 5.4 French), the catheter sheath reduces the annular clearance between the catheter sheath 14 and the inner diameter of the endoscope working channel. By reducing the annular clearance with the working channel of the endoscope, the angle of exit of the catheter sheath 14 of the present invention is coaxial to working channel. This ensures that as the needle exits the distal end of the catheter sheath, the needle will exit the distal end of the catheter in a more “normal” plane relative to the longitudinal axis of the endoscope. The inclusion of an internal taper on the distal end of the catheter sheath, also ensures that the needle exits the catheter in a more “normal” plane than in the case of prior art devices.

FIG. 34 is a side view of an access catheter subassembly of the present invention. As previously described here, the access catheter assembly of the present disclosure may be used in conjunction with minimally-invasive procedures. For example, an access catheter consistent with the present disclosure may be compatible for use with exemplary endoscopic delivery systems and methods discussed in Needle Biopsy Device with Exchangeable Needle and Integrated Needle Protection, U.S. Pub. 2012/0116248, Rapid Exchange FNA Biopsy Device with Diagnostic and Therapeutic Capabilities, U.S. Pub. 2011/0190662, Device for Needle Biopsy with Integrated Needle Protection, U.S. Pub. 2010/0121218, and Needle Biopsy Device, U.S. Pub. 2010/0081965, the contents of each of which are hereby incorporated by reference in their entirety.

As shown in FIG. 34, an access catheter assembly includes an access catheter 200 configured to gain access to and navigate a desired vessel for subsequent treatment thereof. In embodiments described herein, the access catheter 200 is configured to gain access to one or more tissues/organs associated with the pancreaticobiliary system for the purpose of providing treatment. For example, the access catheter 200 may be used, in conjunction with the endoscopic delivery device previously described herein, to gain access and navigate at least the common biliary duct via an Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) technique and to further allow procedures to treat narrowed areas or blockages within the bile duct, including palliative drainage procedures. Accordingly, an access system (access catheter assembly and endoscopic delivery device) consistent with the present disclosure is configured to provide Endoscopic Ultrasound Guided Biliary Drainage (EUS-BD). However, it should be noted that the access system of the present invention is not limited to the pancreaticobiliary system. The access system of the present invention can be used to provide access to a variety of different systems of the human body, particularly where maneuverability and accuracy is desirable.

The access catheter 200 generally includes an elongate tubular body having a proximal section 202 having a proximal end, a distal section 204 having a distal end 208, an outer surface, and an inner surface defining a lumen extending from the proximal section 202 to the distal section 204. The distal section 204 further includes an adjustable portion 206 along a length thereof configured to transition to at least a pre-defined arcuate shape under certain conditions. The proximal section 202 of the catheter 200 is coupled to a catheter hub 17, which is similarly configured as needle hub 17 previously described herein and generally functions in the same manner. As shown in FIG. 35, the access catheter 200 may be configured to receive at least a stylette shaft 22 within. As described in greater detail herein, the stylette may be used during an EUS-BD rendezvous procedure, in which a tip of the stylette may be used to pierce through a wall of the duodenum tissue and through a wall of the common biliary duct (CBD) so as to allow the catheter 200 to gain access into and further navigate the CBD.

The access catheter 200 may have variable stiffness throughout its length. For example, in one embodiment, the proximal and distal sections 202, 204 may have different levels of stiffness. In one embodiment, the proximal section 202 may have a greater level of stiffness than the distal section 204. In some embodiments, the proximal and distal sections 202, 204 may be constructed of the same material, but may have different thickness thereby resulting in different levels of stiffness. For example, the proximal section 202 may have thicker wall while the distal section 204 has a thinner wall, thereby resulting in the proximal section 202 being rigid and the distal section 204 being more flexible.

In other embodiments, the proximal and distal sections 202, 204 may be constructed of different materials that result in different levels of stiffness. For example, the proximal section may be constructed of a relatively rigid material including, but not limited to, various metals (stainless steel, Nitinol, or alloys thereof) and polymers (rigid polyamide, polyurethane, or copolymers thereof). Additionally, or alternatively, the proximal section 202 be braided in construction consisting of inner and outer polymeric jackets, encasing stainless steel braid wire wound in a helically fashion, as generally understood by one skilled in the art.

The distal section 204 may be constructed of a relatively durable and flexible material including, but not limited to, a non-reinforced polymer extrusion from materials such as polyamide, polyurethane, or co-polymer derivatives thereof. In some embodiments, the distal section 204 may be constructed of polymer with braid wire reinforcement, such as previously described.

The proximal section 202 is tubular in design and may have an outer diameter in the range of approximately 0.1 to 0.3 cm. The proximal section 202 may have an inner diameter in the range of 0.03 to 0.3 cm. The transition from the proximal section 202 to the distal section 204 may be located between 5 and 150 cm from the needle hub 17. In some embodiments, the transition is located between 80 and 120 cm from the hub 17. The flexible distal section 204 is of tubular construction and may have an outer diameter in the range of 0.08 and 0.3 cm. In some embodiments, the distal section 204 may have an outer diameter in the range of 0.1 to 0.2 cm.

FIG. 36 is a side view of a distal section of an access catheter 200 of the present invention. As shown, the adjustable portion 206 is configured to transition to a pre-defined arcuate shape under certain conditions. The adjustable portion 206 generally forms a curved shape relative to the longitudinal axis X defined by a lumen of the catheter body. The curved shaped generally has a first transition portion, indicated by arrow 210, upon which the catheter body extends along a curved path until a second transition portion, indicated by arrow 212, at which point the catheter body extends in a relatively linear path to the distal end 208. Accordingly, the adjustable portion 206 has an arcuate-shaped portion 214 between the first and second transition portions 210, 212. The curve styles may vary in length and angulation depending upon the specific tissue/organ and/or location inch which the catheter 200 is to be inserted. When in the pre-defined arcuate shape, the adjustable portion 206 forms at least one angle A relative to a longitudinal axis X defined by the lumen of the catheter body. In one embodiment, the at least one angle A is between 0 and 170 degrees. In some embodiments, the at least one angle A is between 30 and 140 degrees. In another embodiment, the at least one angle A is between 45 and 120 degrees. In another embodiment, the at least one angle A is between 60 and 100 degrees. In a preferred embodiment, the at least one angle A is between 90 and 170 degrees. It should be noted that the adjustable portion 206 may include more than one curved section. For example, the adjustable portion 206 may be of a pigtail configuration, or the like. The different shapes and ranges of curve angles is configured to provide the clinician with sufficient angle options so as to satisfy the variation in anatomy and aid in guidewire advancement.

FIG. 37A is a side view, partly in section, of storage of the access catheter 200 within the catheter sheath 14 of FIG. 5 including a stylette shaft 22 positioned within the access catheter 200. As previously described herein, the access catheter 200 is to be used in conjunction with the delivery system handle 10 previously described herein. Accordingly, the access catheter 200, as well as the hub 17, may be removably disposed within the inner lumen of the delivery handle assembly and lumen of the catheter sheath 14. In this instance, a stylette shaft 22 is also positioned within the lumen 215 of the catheter 200. A shown, when disposed within the lumen of the catheter sheath 14, the adjustable portion 206 of the access catheter 200 is configured to maintain a substantially linear shape, or at the very least, maintain a shape that corresponds to contour of the catheter sheath 14. In other words, while loaded within the catheter sheath 14, the distal section 204, including the adjustable portion 206, are constructed of sufficiently flexible materials configured to correspond to the shape of the lumen of the catheter sheath 14.

As shown in FIG. 37B, even upon extension of the access catheter 200 and stylette shaft 22, as indicated by arrow 218, the adjustable portion 206 of the catheter 200 is configured to maintain a substantially linear shape. In particular, while the relatively rigid stylette shaft 22 is positioned within the distal section 204, specifically the adjustable portion 206, of the catheter 200, the adjustable portion 206 is prevented from transitioning to the pre-defined arcuate shape. In this instance, the distal pointed tip 216 of the stylette shaft 22 can be used to pierce the tissue of a vessel (e.g., pierce the wall of the duodenum and the wall of the common biliary duct) so as to allow the catheter 200 to gain access to the vessel.

FIG. 37C is a side view, partly in section, of withdrawal of the stylette shaft 22 from within a portion of the distal section 204 of the access catheter 200. As shown, upon withdrawal of the stylette, as indicated by arrow 220, the adjustable portion 206 is configured to transition to the pre-defined arcuate shape. This will generally occur once adjustable portion 206 has been guided through the puncture between the duodenum and common biliary duct. Accordingly, the adjustable portion 206 may be constructed of flexible materials having shape memory properties. As shown in FIG. 37D, further extension of the access catheter 200 from the catheter sheath 14, as indicated by arrow 222, may result in the adjustable portion 206 fully transitioning to the arcuate shape. At this point, the lumen of the catheter 200 at the distal end 208 may be in relative coaxial alignment with the lumen of the common biliary duct, thereby providing a clinician with an improved initial access to the duct for additional tools (e.g., guidewire) to continue the biliary drainage procedure.

FIG. 38 is a side view, partly in section, of the extended distal end 208 of the access catheter 200 illustrating manipulation of the distal end 208 and adjustable portion 206 based on rotational movement of a catheter hub 17. As described in greater detail herein, the handle assembly 10 includes one or more elements configured to allow a clinician to maneuver and manipulate the adjustable portion 206 and distal end 208 of the access catheter 200 while navigating the vessel. For example, a clinician may rotate the catheter hub 17, as indicated by arrow 224, which, in turn, results in rotational movement of the adjustable portion 206 and distal end 208, as indicated by arrow 226. Accordingly, a clinician may be able to manipulate the catheter 200 so as to better navigate the vessel. The adjustable portion 206 may rotate incrementally within a range of 0 to 360 degrees relative to the longitudinal axis X. For example, the clinician may rotate the hub 17 approximately 180 degrees, thereby resulting the adjustable portion rotating 180 degrees (206a position to 206b position).

FIG. 39 is a perspective view of the inner hub housing 27 of the delivery handle assembly 10 and the catheter hub 17 of the access catheter assembly. As previously described herein, and shown in FIG. 24, the inner hub housing 27 contains depressed female détentes 40 positioned between adjacent radially spaced barbs on the inner diameter of the inner hub housing 27. These détentes 40 are equispaced around the internal circumference of the hub housing body. The détente features provide a mechanical lock with corresponding interlocking barbs 41a on the external surface of the catheter hub 17. Each of the second plurality of barbs 41a are configured for selective engagement with a corresponding one of the first plurality of barbs and the corresponding female détentes 40 so as to permit incremental rotation of the catheter hub 17 relative to the inner hub housing 27. Each of the second plurality of barbs 41a differ from the barbs 41 previously described herein in that the barbs 41a have a reduced height so as to provide incremental interference. In other words, rather than being completely locked into corresponding détentes, the reduced height of the barbs 41a allows a temporary engagement, wherein, upon sufficient rotational force, the each barb 41a can move incrementally from détente to détente. Accordingly, the distal section 204, specifically the adjustable portion 206 and distal end 208 of the access catheter 200 is configured to incrementally rotate about the longitudinal axis X in conjunction with incremental rotation of the catheter hub 17. As such, upon removal of rotational force, engagement between inner hub housing 27 and catheter hub 17 is sufficient to ensure that the distal section, particularly the adjustable portion 206, remains fixed the desired location and does not whip, and further allows a clinician may remove their grip from the handle assembly, while the position of the distal section is maintained.

FIG. 40 is a side view of another embodiment of a distal section of an access catheter of the present invention. As shown, the adjustable portion 206a may include a metallic distal tip 228 adjacent to the distal end 208. The metallic distal tip 228 may be coupled to the catheter by any known techniques. For example, in one embodiment, the metallic distal tip 228 may be thermally bonded to the distal end 208 of the catheter 200. The metallic distal tip 228 may provide sufficient durability and column strength and pushability for allowing the distal end 208 to puncture through relatively tough, dense, and/or fibrous tissue, such as through the duodenal or gastric walls and into the biliary tree. The metallic distal tip 228 may vary in length between 2 and 30 mm. In one embodiment, the metallic distal tip 228 may have a length in the range of 2 to 10 mm. The outer surface of the metallic distal tip 228 enhanced echogenicity or acoustic reflection. For example, this echogenically enhanced region can be fabricated by, but not limited to, roughening the metallic distal tip 228 over a pre-defined length. The length of the echogenically enhanced region may be in the range of 2 mm to 20 mm, but is more preferably in the range of 10 mm to 15 mm. The echogenic enhanced pattern may be imparted to the metallic distal tip 228 via a micro-blasting process which roughens the surface of the catheter over a specific length, improving the visibility of the metallic distal tip 228 under endoscopic ultrasound. Other surface roughening techniques may be used, such as laser or chemical etching. In other embodiments, the echogenically enhanced region of the metallic distal tip 228 may be achieved through the removal of material from the surface of the metallic distal tip 228 to provide greater reflectivity and strengthened reflected signal.

FIG. 41 is a side view of another embodiment of a distal section of an access catheter of the present invention. In the illustrated embodiment, the access catheter 200 further includes a cutting element 230 positioned on the adjustable portion 206b and adjacent to the distal end 208. As generally understood, the cutting element 230 may be embodiment as any element configured to excise, cut, ablate, or otherwise remove tissue and/or debris. For example, the cutting element 230 may include, but is not limited to, a dielectric cautery ring, cutting knife, a cutting wire, pinching cutters, or the like. The cutting element 230 is configured to allow the clinician to ablate/cut through tissue so as to widen an obstructed pathway and/or completely remove a tumor or other obstruction (e.g., gallstone).

FIG. 42 is a side view of another embodiment of a distal section of an access catheter of the present invention and FIG. 43 is a cross sectional view of a portion of the distal section of the access catheter of FIG. 42. As shown, the access catheter 200 may further includes at least one control element configured to cause movement of at least the distal end 208 and/or the adjustable portion 206c of the catheter 200 relative to a longitudinal axis X. For example, the catheter 200 may have steerable functionality, such that one or more control, or steering, wires 232 may be positioned within and anchored to at least the distal section 204 of the catheter 200, such that force applied to the one or more control wires 232 results in manipulation of at least the distal end 208 (shown as 208a, 208b). Control over the control wires 232 may be provided within the handle assembly 10 and/or separately on the catheter hub 17. Accordingly, upon a clinician applying tension to one or more control wires 232, at least the distal end 208 will move so as to provide improved manipulation for improving navigation of the catheter 200.

FIG. 44 is a side view of another embodiment of a distal section of an access catheter of the present invention. As shown, at least the distal section 204 of the catheter 200 includes a tubular body formed from densely packed tubular coil. In some embodiments, the interior surface of the lumen of the distal section 204 has a liner disposed thereon having a relatively low coefficient of friction. For example, the liner may be a polytetrafluoroethylene (PTFE) liner. By providing a line having a low coefficient of friction, lubricity is enhance lubricity and guidewire movement. Additionally, such a coiled configuration is configured to enhance flexibility for access catheter advancement while also enhancing torque transmission from the hub 17 during rotational manipulation.

Accordingly, the access system of the present invention provides a clinician with the ability manipulate the adjustable portion of the distal section, particularly when the adjustable portion is in the pre-defined arcuate shape, thereby providing an increased overall range of motion to allow improved manipulation during navigation of a vessel. Thus, the access system of the present invention provides access to the appropriate vessel (e.g., biliary duct), allows manipulation of the catheter, as well as other tools (e.g., guidewire) into position so as to achieve trans-papillary placement (across the ampulla of Vater), and further achieve internal drainage of the biliary duct (e.g., via placement of a stent), all without having to perform a scope exchange (as current techniques require US scope to ERCP scope exchanges during rendezvous procedure for biliary duct drainage).

While several embodiments of the present disclosure have been described and illustrated herein, those of ordinary skill in the art will readily envision a variety of other means and/or structures for performing the functions and/or obtaining the results and/or one or more of the advantages described herein, and each of such variations and/or modifications is deemed to be within the scope of the present disclosure. More generally, those skilled in the art will readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that the actual parameters, dimensions, materials, and/or configurations will depend upon the specific application or applications for which the teachings of the present disclosure is/are used.

Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the disclosure described herein. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto, the disclosure may be practiced otherwise than as specifically described and claimed. The present disclosure is directed to each individual feature, system, article, material, kit, and/or method described herein. In addition, any combination of two or more such features, systems, articles, materials, kits, and/or methods, if such features, systems, articles, materials, kits, and/or methods are not mutually inconsistent, is included within the scope of the present disclosure.

All definitions, as defined and used herein, should be understood to control over dictionary definitions, definitions in documents incorporated by reference, and/or ordinary meanings of the defined terms.

The indefinite articles “a” and “an,” as used herein in the specification and in the claims, unless clearly indicated to the contrary, should be understood to mean “at least one.”

The phrase “and/or,” as used herein in the specification and in the claims, should be understood to mean “either or both” of the elements so conjoined, i.e., elements that are conjunctively present in some cases and disjunctively present in other cases. Other elements may optionally be present other than the elements specifically identified by the “and/or” clause, whether related or unrelated to those elements specifically identified, unless clearly indicated to the contrary.

Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.

The terms and expressions which have been employed herein are used as terms of description and not of limitation, and there is no intention, in the use of such terms and expressions, of excluding any equivalents of the features shown and described (or portions thereof), and it is recognized that various modifications are possible within the scope of the claims. Accordingly, the claims are intended to cover all such equivalents.

INCORPORATION BY REFERENCE

References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.

EQUIVALENTS

Various modifications of the invention and many further embodiments thereof, in addition to those shown and described herein, will become apparent to those skilled in the art from the full contents of this document, including references to the scientific and patent literature cited herein. The subject matter herein contains important information, exemplification and guidance that can be adapted to the practice of this invention in its various embodiments and equivalents thereof.

Claims

1. A system for providing access to a vessel, the system comprising: an adjustable delivery handle system comprising:a delivery handle assembly, at least a portion of which comprises an inner lumen configured to receive one of a plurality of exchangeable subassemblies; andan inner hub housing coupled to a portion of the deliver handle assembly, the inner hub housing having a first plurality of radially-spaced barbs disposed on an inner diameter thereof;a sheath coupled to a distal end of the handle assembly and having a lumen in fluid communication with the inner lumen of the delivery handle assembly; andan access catheter subassembly removably disposed within the inner lumen of the delivery handle assembly and lumen of the sheath, the access catheter subassembly comprising:a catheter hub configured for insertion into the inner hub housing, the catheter hub having a second plurality of radially-spaced barbs disposed on an outer diameter thereof, wherein each of the second plurality of radially-spaced barbs are configured for selective engagement with a corresponding one of the first plurality of radially-spaced barbs to permit incremental rotation of the catheter hub relative to the inner hub housing; andan access catheter having an elongate tubular catheter body having a proximal section having a proximal end, a distal section having a distal end, an outer surface, and an inner surface defining a lumen extending from the proximal end to the distal end,wherein the distal section of the access catheter is configured to incrementally rotate about a longitudinal axis defined by the lumen of the catheter body in conjunction with incremental rotation of the catheter hub.
2. The system of claim 1, wherein the distal section includes an adjustable portion along a length thereof configured to transition to a pre-defined arcuate shape.
3. The system of claim 2, wherein, when disposed within the lumen of the sheath, the adjustable portion of the distal section of the access catheter is configured to maintain a substantially linear shape.
4. The system of claim 2, wherein, upon extension from the lumen of the sheath, the adjustable portion of the distal section of the access catheter is configured to transition to the pre-defined arcuate shape.
5. The system of claim 2, wherein, when in the pre-defined arcuate shape, the adjustable portion forms at least one angle relative to the longitudinal axis defined by the lumen of the catheter body, wherein the at least one angle is between 0 and 170 degrees.
6. The system of claim 2, further comprising a stylette member removably disposed within the inner lumen of the delivery handle assembly, lumen of the sheath, and lumen of the access catheter, the stylette member having a distal end configured to pierce tissue of the vessel to provide access to an interior of the vessel.
7. The system of claim 6, wherein the adjustable portion is configured to maintain a substantially linear shape when the stylette member is disposed within a lumen of the adjustable portion of the distal section of the access catheter.
8. The system of claim 7, wherein the adjustable portion is configured to transition to the pre-defined arcuate shape upon removal of the stylette member from within the lumen of the adjustable portion.
9. The system of claim 1, wherein the proximal section and the distal section of the access catheter have different levels of stiffness.
10. The system of claim 9, wherein the proximal section has a greater level of stiffness than the distal section.
11. The system of claim 1, wherein the distal section of the access catheter further comprises a portion adjacent the distal end having enhanced echogenicity or acoustic reflection.
12. The system of claim 1, wherein the distal section of the access catheter has a metallic distal tip.
13. The system of claim 1, wherein the distal section of the access catheter comprises a tubular body formed from densely packed tubular coil.
14. The system of claim 13, wherein an interior surface of the lumen of the distal section has a liner disposed thereon having a coefficient of friction.
15. The system of claim 1, wherein the access catheter further comprises a cutting element positioned on the distal section adjacent to the distal end.
16. The system of claim 1, wherein the access catheter further comprises at least one control element configured to cause movement of at least the distal end relative to the longitudinal axis defined by the lumen of the catheter body upon application of force thereto.

CROSS-REFERENCE TO RELATED APPLICATIONS

This patent application is a continuation of U.S. patent application Ser. No. 14/494,685, filed Sep. 24, 2014, now U.S. Pat. No. 9,782,565, issued Oct. 10, 2017, which is a continuation-in-part of U.S. patent application Ser. No. 13/297,766, filed Nov. 16, 2011, now U.S. Pat. No. 9,332,973, issued May 10, 2016, which is a continuation-in-part of U.S. patent application Ser. No. 13/029,593, filed Feb. 17, 2011, which claims priority to and benefit of U.S. Provisional Application Ser. No. 61/305,304, filed Feb. 17, 2010, and U.S. provisional Application Ser. No. 61/305,396, filed Feb. 17, 2010. U.S. patent application Ser. No. 13/029,593, filed Feb. 17, 2011, is also a continuation-in-part of U.S. patent application Ser. No. 12/607,636, filed Oct. 28, 2009, now U.S. Pat. No. 8,968,210, issued Mar. 3, 2015, which claims priority to and benefit of U.S. Provisional Application Ser. No. 61/117,966, filed Nov. 26, 2008. U.S. patent application Ser. No. 13/029,593, filed Feb. 17, 2011, also claims priority to and benefit of U.S. Provisional Application Ser. No. 61/152,741, filed Feb. 16, 2009. U.S. patent application Ser. No. 12/607,636, filed Oct. 28, 2009, now U.S. Pat. No. 8,968,210, issued Mar. 3, 2015, is also a continuation-in-part of U.S. patent application Ser. No. 12/243,367, filed Oct. 1, 2008, now U.S. Pat. No. 9,186,128, issued Nov. 17, 2015. The entire contents of each of the above-mentioned applications are incorporated by reference herein in their entirety.

US Referenced Citations (747)

Number	Name	Date	Kind
3612050	Sheridan	Oct 1971	A
3666808	Meek	May 1972	A
4096860	McLaughlin	Jun 1978	A
4249541	Pratt	Feb 1981	A
4356828	Jamshidi	Nov 1982	A
4467816	Schluter et al.	Aug 1984	A
4655226	Lee	Apr 1987	A
4819637	Dormandy, Jr. et al.	Apr 1989	A
4838280	Haaga	Jun 1989	A
4861341	Woodburn	Aug 1989	A
4893635	de Groot et al.	Jan 1990	A
4903523	Flynn	Feb 1990	A
4966162	Wang	Oct 1990	A
4995866	Amplatz et al.	Feb 1991	A
5054310	Flynn	Oct 1991	A
5057085	Kopans	Oct 1991	A
5111829	Alvarez de Toledo	May 1992	A
5131393	Ishiguro et al.	Jul 1992	A
5167239	Cohen et al.	Dec 1992	A
5215528	Purdy et al.	Jun 1993	A
5257628	Ishiguro et al.	Nov 1993	A
5266359	Spielvogel	Nov 1993	A
5277199	DuBois et al.	Jan 1994	A
5281408	Unger	Jan 1994	A
5320627	Sorensen et al.	Jun 1994	A
5333613	Tickner et al.	Aug 1994	A
5368036	Tanaka et al.	Nov 1994	A
5380292	Wilson	Jan 1995	A
5385561	Cerny	Jan 1995	A
5419310	Frassica et al.	May 1995	A
5458112	Weaver	Oct 1995	A
5470308	Edwards et al.	Nov 1995	A
5471988	Fujio et al.	Dec 1995	A
5480389	McWha et al.	Jan 1996	A
5490521	Davis et al.	Feb 1996	A
5526822	Burbank et al.	Jun 1996	A
5595562	Grier	Jan 1997	A
5595724	Deutsch et al.	Jan 1997	A
5601588	Tonomura et al.	Feb 1997	A
5607389	Edwards et al.	Mar 1997	A
5609850	Deutsch et al.	Mar 1997	A
5636255	Ellis	Jun 1997	A
5681348	Sato	Oct 1997	A
5688490	Tournier et al.	Nov 1997	A
5695491	Silverstein	Dec 1997	A
5775333	Burbank et al.	Jul 1998	A
5800445	Ratcliff et al.	Sep 1998	A
5801057	Smart et al.	Sep 1998	A
5810806	Ritchart et al.	Sep 1998	A
5810835	Ryan	Sep 1998	A
5820609	Saito	Oct 1998	A
5848978	Cecchi	Dec 1998	A
5888201	Stinson et al.	Mar 1999	A
5902310	Foerster et al.	May 1999	A
5919172	Golba, Jr.	Jul 1999	A
5921933	Sarkis et al.	Jul 1999	A
5928164	Burbank et al.	Jul 1999	A
5938635	Kuhle	Aug 1999	A
5941890	Voegele et al.	Aug 1999	A
5944673	Gregoire et al.	Aug 1999	A
5947964	Eggers et al.	Sep 1999	A
5964740	Ouchi	Oct 1999	A
5967988	Briscoe et al.	Oct 1999	A
5968022	Saito	Oct 1999	A
5980469	Burbank et al.	Nov 1999	A
6019733	Farascioni	Feb 2000	A
6045497	Schweich, Jr. et al.	Apr 2000	A
6080115	Rubinstein	Jun 2000	A
6106473	Violante et al.	Aug 2000	A
6106524	Eggers et al.	Aug 2000	A
6117108	Woehr et al.	Sep 2000	A
6126633	Kaji	Oct 2000	A
6133316	Ostensen et al.	Oct 2000	A
6149598	Tanaka	Nov 2000	A
6161034	Burbank et al.	Dec 2000	A
6168779	Barsky et al.	Jan 2001	B1
6171249	Chin et al.	Jan 2001	B1
6174291	McMahon et al.	Jan 2001	B1
6179809	Khairkhahan et al.	Jan 2001	B1
6190360	Iancea	Feb 2001	B1
6193692	Harris et al.	Feb 2001	B1
6203507	Wadsworth	Mar 2001	B1
6221622	Love	Apr 2001	B1
6228039	Binmoeller	May 2001	B1
6228049	Schroeder et al.	May 2001	B1
6231515	Moore et al.	May 2001	B1
6261302	Voegele et al.	Jul 2001	B1
6273861	Bates et al.	Aug 2001	B1
6280399	Rossin et al.	Aug 2001	B1
6287304	Eggers et al.	Sep 2001	B1
6312428	Eggers et al.	Nov 2001	B1
6323335	Huang	Nov 2001	B1
6328701	Terwilliger	Dec 2001	B1
6333155	Lockhart et al.	Dec 2001	B1
6334067	Brabrand	Dec 2001	B1
6336812	Cooper et al.	Jan 2002	B1
6337994	Stoianovici et al.	Jan 2002	B1
6338968	Hefti	Jan 2002	B1
6340563	Finkelstein et al.	Jan 2002	B1
6340565	Oliner et al.	Jan 2002	B1
6340568	Hefti	Jan 2002	B2
6344316	Lockhart et al.	Feb 2002	B1
6344317	Urnovitz	Feb 2002	B2
6347240	Foley et al.	Feb 2002	B1
6347241	Burbank et al.	Feb 2002	B2
6350244	Fisher	Feb 2002	B1
6350274	Li	Feb 2002	B1
6350583	Cohen et al.	Feb 2002	B1
6351660	Burke et al.	Feb 2002	B1
6355033	Moorman et al.	Mar 2002	B1
6355275	Klein	Mar 2002	B1
6355424	Lorincz et al.	Mar 2002	B1
6356782	Sirimanne et al.	Mar 2002	B1
6361499	Bates et al.	Mar 2002	B1
6361948	Tricoli et al.	Mar 2002	B1
6364526	Ivan et al.	Apr 2002	B2
6365362	Terstappen et al.	Apr 2002	B1
6365712	Kelly	Apr 2002	B1
6368280	Cermak et al.	Apr 2002	B1
6368292	Ogden et al.	Apr 2002	B1
6368792	Billing-Medel et al.	Apr 2002	B1
6368795	Hefti	Apr 2002	B1
6368799	Chee	Apr 2002	B1
6369195	An et al.	Apr 2002	B1
6371904	Sirimanne et al.	Apr 2002	B1
6371917	Ferrara et al.	Apr 2002	B1
6372431	Cunningham et al.	Apr 2002	B1
6372444	Powers et al.	Apr 2002	B1
6374135	Bucholz	Apr 2002	B1
6375634	Carroll	Apr 2002	B1
6375953	Srivastava et al.	Apr 2002	B1
6376258	Hefti	Apr 2002	B2
6379671	Colpitts	Apr 2002	B1
6379672	Srivastava et al.	Apr 2002	B1
6383484	Achen et al.	May 2002	B1
6383491	Srivastava et al.	May 2002	B1
6383492	Srivastava et al.	May 2002	B1
6383493	Srivastava et al.	May 2002	B1
6387056	Kieturakis	May 2002	B1
6387374	Srivastava et al.	May 2002	B1
6387629	Schneider et al.	May 2002	B1
6391306	Srivastava et al.	May 2002	B1
6391542	Anderson et al.	May 2002	B1
6391543	Billing-Medel et al.	May 2002	B2
6394965	Klein	May 2002	B1
6395480	Hefti	May 2002	B1
6398737	Moore et al.	Jun 2002	B2
6399069	Srivastava et al.	Jun 2002	B1
6399070	Srivastava et al.	Jun 2002	B1
6399371	Falduto et al.	Jun 2002	B1
6402701	Kaplan et al.	Jun 2002	B1
6403095	Srivastava et al.	Jun 2002	B1
6405733	Fogarty et al.	Jun 2002	B1
6407125	Fernandez-Pol	Jun 2002	B1
6409664	Kattan et al.	Jun 2002	B1
6410028	Srivastava	Jun 2002	B1
6410229	Lockhart et al.	Jun 2002	B1
6413751	Benkovic et al.	Jul 2002	B1
6416484	Miller et al.	Jul 2002	B1
6421559	Pearlman	Jul 2002	B1
6423081	Lee et al.	Jul 2002	B1
6423313	Esmon et al.	Jul 2002	B1
6423489	Anderson et al.	Jul 2002	B1
6423494	Jin et al.	Jul 2002	B1
6423503	Mikolajczyk et al.	Jul 2002	B1
6426195	Zhong et al.	Jul 2002	B1
6426367	Das	Jul 2002	B1
6427081	Burbank et al.	Jul 2002	B1
6427089	Knowlton	Jul 2002	B1
6428463	Ravins et al.	Aug 2002	B1
6428479	Aksnes et al.	Aug 2002	B1
6428487	Burdorff et al.	Aug 2002	B1
6432035	Ravins et al.	Aug 2002	B1
6432053	Fecht et al.	Aug 2002	B1
6432065	Burdorff et al.	Aug 2002	B1
6432700	Henderson et al.	Aug 2002	B1
6434415	Foley et al.	Aug 2002	B1
6436054	Viola et al.	Aug 2002	B1
6436120	Meglin	Aug 2002	B1
6436394	Henderson et al.	Aug 2002	B1
6436404	Srivastava et al.	Aug 2002	B1
6436411	Riordan et al.	Aug 2002	B1
6440086	Hohenberg	Aug 2002	B1
6440147	Lee et al.	Aug 2002	B1
6440151	Cragg et al.	Aug 2002	B1
6440153	Cragg et al.	Aug 2002	B2
6443960	Brabrand	Sep 2002	B1
6445767	Karellas	Sep 2002	B1
6447477	Burney et al.	Sep 2002	B2
6447534	Cragg et al.	Sep 2002	B2
6447780	Srivastava et al.	Sep 2002	B1
6447781	Srivastava	Sep 2002	B1
6447997	Los et al.	Sep 2002	B1
6448020	Toftgard et al.	Sep 2002	B1
6450973	Murphy	Sep 2002	B1
6455027	Barsky et al.	Sep 2002	B1
6455048	Srivastava et al.	Sep 2002	B1
6455251	Waldman	Sep 2002	B1
6459925	Nields et al.	Oct 2002	B1
6461615	Srivastava	Oct 2002	B1
6463319	Bucholz	Oct 2002	B1
6464648	Nakamura	Oct 2002	B1
6465181	Billing-Medel et al.	Oct 2002	B2
6465183	Wolber	Oct 2002	B2
6468985	Huang	Oct 2002	B1
6470217	Fenn et al.	Oct 2002	B1
6471659	Eggers et al.	Oct 2002	B2
6471700	Burbank et al.	Oct 2002	B1
6471709	Fawzi et al.	Oct 2002	B1
6472518	Ribot et al.	Oct 2002	B1
6475732	Shayesteh et al.	Nov 2002	B1
6475789	Cech et al.	Nov 2002	B1
6477426	Fenn et al.	Nov 2002	B1
6482182	Carroll et al.	Nov 2002	B1
6482599	Mikolajczyk et al.	Nov 2002	B1
6485308	Goldstein	Nov 2002	B1
6485436	Truckai et al.	Nov 2002	B1
6485905	Hefti	Nov 2002	B2
6488636	Bryan et al.	Dec 2002	B2
6489097	Hirose et al.	Dec 2002	B2
6489113	Traish	Dec 2002	B1
6490467	Bucholz et al.	Dec 2002	B1
6491699	Henderson et al.	Dec 2002	B1
6491702	Heilbrun et al.	Dec 2002	B2
6492115	Guida et al.	Dec 2002	B1
6494844	Van Bladel et al.	Dec 2002	B1
6494859	Love et al.	Dec 2002	B2
6494879	Lennox et al.	Dec 2002	B2
6495130	Henderson et al.	Dec 2002	B1
6496717	Cox et al.	Dec 2002	B2
6497706	Burbank et al.	Dec 2002	B1
6500622	Bruchez, Jr. et al.	Dec 2002	B2
6500938	Au-Young et al.	Dec 2002	B1
6505125	Ho	Jan 2003	B1
6506156	Jones et al.	Jan 2003	B1
6506607	Shyjan	Jan 2003	B1
6507748	Selland	Jan 2003	B2
6508755	Ravins et al.	Jan 2003	B1
6508789	Sinnott et al.	Jan 2003	B1
6509458	Afar et al.	Jan 2003	B1
6509514	Kneteman et al.	Jan 2003	B1
6514248	Eggers et al.	Feb 2003	B1
6514251	Ni et al.	Feb 2003	B1
6514685	Moro	Feb 2003	B1
6514695	Barsky et al.	Feb 2003	B1
6517498	Burbank et al.	Feb 2003	B1
6521211	Unger et al.	Feb 2003	B1
6524800	Lockhart et al.	Feb 2003	B2
6527731	Weiss et al.	Mar 2003	B2
6530888	Smith et al.	Mar 2003	B2
6535756	Simon et al.	Mar 2003	B1
6537761	Shayesteh et al.	Mar 2003	B1
6538119	Billing-Medel et al.	Mar 2003	B2
6540694	Van Bladel et al.	Apr 2003	B1
6540695	Burbank et al.	Apr 2003	B1
6544236	Cragg et al.	Apr 2003	B1
6544544	Hunter et al.	Apr 2003	B2
6546787	Schiller et al.	Apr 2003	B1
6548257	Lockhart et al.	Apr 2003	B2
6551255	Van Bladel et al.	Apr 2003	B2
6551784	Fodor et al.	Apr 2003	B2
6552164	Colpitts et al.	Apr 2003	B1
6552181	Dean et al.	Apr 2003	B1
6554779	Viola et al.	Apr 2003	B2
6558407	Ivanko et al.	May 2003	B1
6558916	Veerapandian et al.	May 2003	B2
6562562	Casu' et al.	May 2003	B2
6564087	Pitris et al.	May 2003	B1
6564806	Fogarty et al.	May 2003	B1
6566078	Raitano et al.	May 2003	B1
6566079	Hefti	May 2003	B2
6567214	Lorincz	May 2003	B2
6567689	Burbank et al.	May 2003	B2
6568941	Goldstein	May 2003	B1
6572551	Smith et al.	Jun 2003	B1
6572578	Blanchard	Jun 2003	B1
6577904	Zhang et al.	Jun 2003	B1
6579891	Fernandez-Pol	Jun 2003	B1
6580938	Acker	Jun 2003	B1
6582368	Holdaway et al.	Jun 2003	B2
6582426	Moorman et al.	Jun 2003	B2
6585968	Little et al.	Jul 2003	B2
6586713	Essenfeld et al.	Jul 2003	B2
6587578	Godik et al.	Jul 2003	B2
6589240	Hinchliffe	Jul 2003	B2
6592508	Ravins et al.	Jul 2003	B1
6592530	Farhadi	Jul 2003	B1
6599247	Stetten	Jul 2003	B1
6602659	Waldman et al.	Aug 2003	B1
6604404	Paltieli et al.	Aug 2003	B2
6605294	Sawhney	Aug 2003	B2
6607561	Brannon	Aug 2003	B2
6608191	Anderson et al.	Aug 2003	B1
6608310	Soluri et al.	Aug 2003	B2
6610016	Violante et al.	Aug 2003	B1
6610499	Fulwyler et al.	Aug 2003	B1
6610839	Morin et al.	Aug 2003	B1
6612991	Sauer et al.	Sep 2003	B2
6613740	Gozes et al.	Sep 2003	B1
6614921	Chung et al.	Sep 2003	B1
6617110	Chech et al.	Sep 2003	B1
6617137	Dean et al.	Sep 2003	B2
6623437	Hinchliffe et al.	Sep 2003	B2
6626832	Paltieli et al.	Sep 2003	B1
6626848	Neuenfeldt	Sep 2003	B2
6626850	Kupec et al.	Sep 2003	B1
6626903	McGuckin, Jr. et al.	Sep 2003	B2
6626930	Allen et al.	Sep 2003	B1
6627414	Billing-Medel et al.	Sep 2003	B2
6627461	Chapman et al.	Sep 2003	B2
6629959	Kuracina et al.	Oct 2003	B2
6631204	Smith	Oct 2003	B1
6632183	Bowman et al.	Oct 2003	B2
6638234	Burbank et al.	Oct 2003	B2
6638719	Gunderson et al.	Oct 2003	B1
6638727	Hung et al.	Oct 2003	B1
6645731	Terstappen et al.	Nov 2003	B2
6647285	Da Silva et al.	Nov 2003	B2
6649420	Cantor	Nov 2003	B1
6652520	Moorman et al.	Nov 2003	B2
6652859	Afar et al.	Nov 2003	B1
6653080	Bruchez et al.	Nov 2003	B2
6653129	Bander et al.	Nov 2003	B1
6654120	Ban	Nov 2003	B2
6654629	Montegrande	Nov 2003	B2
6656132	Ouchi	Dec 2003	B1
6659105	Burbank et al.	Dec 2003	B2
6660834	Billing-Medel et al.	Dec 2003	B2
6662041	Burbank et al.	Dec 2003	B2
6663560	MacAulay et al.	Dec 2003	B2
6666811	Good	Dec 2003	B1
6670122	Rosenow et al.	Dec 2003	B2
6673023	Pflueger	Jan 2004	B2
6673914	Hoon	Jan 2004	B1
6675037	Tsekos	Jan 2004	B1
6676610	Morton et al.	Jan 2004	B2
6676658	Burbank et al.	Jan 2004	B2
6676935	Henderson et al.	Jan 2004	B2
6676984	Sharp et al.	Jan 2004	B1
6677157	Cohen	Jan 2004	B1
6678545	Bucholz	Jan 2004	B2
6678552	Perlman	Jan 2004	B2
6679851	Burbank et al.	Jan 2004	B2
6680178	Harris et al.	Jan 2004	B2
6689062	Mesallum	Feb 2004	B1
6689065	Aksnes et al.	Feb 2004	B2
6689067	Sauer et al.	Feb 2004	B2
6689071	Burbank et al.	Feb 2004	B2
6689072	Kaplan et al.	Feb 2004	B2
6689073	Quay	Feb 2004	B2
6689744	Gao et al.	Feb 2004	B2
6689787	McKearn et al.	Feb 2004	B1
6690371	Okerlund et al.	Feb 2004	B1
6690966	Rava et al.	Feb 2004	B1
6690976	Fenn et al.	Feb 2004	B2
6692467	McFarlane	Feb 2004	B2
6692724	Yang et al.	Feb 2004	B1
6692736	Yu et al.	Feb 2004	B2
6695779	Sauer et al.	Feb 2004	B2
6697665	Rava et al.	Feb 2004	B1
6699205	Fulton, III et al.	Mar 2004	B2
6702749	Paladini et al.	Mar 2004	B2
6702761	Damadian et al.	Mar 2004	B1
6702831	Lee et al.	Mar 2004	B2
6703216	Parsons et al.	Mar 2004	B2
6705994	Vortman et al.	Mar 2004	B2
6709408	Fisher	Mar 2004	B2
6709816	Huang et al.	Mar 2004	B1
6712773	Viola	Mar 2004	B1
6712785	Morton et al.	Mar 2004	B2
6714808	Klimberg et al.	Mar 2004	B2
6716179	Burbank et al.	Apr 2004	B2
6722371	Fogarty et al.	Apr 2004	B1
6723052	Mills	Apr 2004	B2
6723106	Charles et al.	Apr 2004	B1
6723498	Shyjan et al.	Apr 2004	B1
6725080	Melkent et al.	Apr 2004	B2
6725083	Burbank et al.	Apr 2004	B1
6725095	Fenn et al.	Apr 2004	B2
6726651	Robinson et al.	Apr 2004	B1
6728334	Zhao	Apr 2004	B1
6730042	Fulton et al.	May 2004	B2
6730045	Finer	May 2004	B2
6731966	Spigelman et al.	May 2004	B1
6733969	Mack	May 2004	B2
6738663	Schroeppel et al.	May 2004	B2
6746844	Oliner et al.	Jun 2004	B2
6750015	Horwitz et al.	Jun 2004	B2
6752154	Fogarty et al.	Jun 2004	B2
6752767	Turovskiy et al.	Jun 2004	B2
6752768	Burdorff et al.	Jun 2004	B2
6752769	Alberico	Jun 2004	B2
6753138	Schneider et al.	Jun 2004	B1
6758848	Burbank et al.	Jul 2004	B2
6764449	Lee et al.	Jul 2004	B2
6764495	Lee et al.	Jul 2004	B2
6766186	Hoyns et al.	Jul 2004	B1
6767704	Waldman et al.	Jul 2004	B2
6768925	Fenn et al.	Jul 2004	B2
6770066	Weaver et al.	Aug 2004	B1
6770070	Balbierz	Aug 2004	B1
6770435	Billing-Medel et al.	Aug 2004	B1
6770770	Baumann et al.	Aug 2004	B1
6773903	Bova	Aug 2004	B2
6776757	Larson et al.	Aug 2004	B2
6780984	Wang et al.	Aug 2004	B2
6785410	Vining et al.	Aug 2004	B2
6786870	Miyaki et al.	Sep 2004	B2
6788977	Fenn et al.	Sep 2004	B2
6790185	Fisher et al.	Sep 2004	B1
6797477	Guida et al.	Sep 2004	B2
6805669	Swanbom	Oct 2004	B2
6805869	Guo	Oct 2004	B2
6806712	Akgun	Oct 2004	B2
6807444	Tu et al.	Oct 2004	B2
6808878	Gray et al.	Oct 2004	B1
6818184	Fulwyler et al.	Nov 2004	B2
6818750	Reed	Nov 2004	B2
6819785	Vining et al.	Nov 2004	B1
6821725	Carrasco et al.	Nov 2004	B1
6824780	Devaux et al.	Nov 2004	B1
6824974	Pisharody et al.	Nov 2004	B2
6824995	Wu	Nov 2004	B1
6827692	Castellacci	Dec 2004	B2
6831059	Donovan	Dec 2004	B2
6832111	Tu et al.	Dec 2004	B2
6833373	McKearn et al.	Dec 2004	B1
6833438	Afar et al.	Dec 2004	B1
6835183	Lennox et al.	Dec 2004	B2
6835572	Mountford et al.	Dec 2004	B1
6838243	Lai et al.	Jan 2005	B2
6840952	Saker et al.	Jan 2005	B2
6841350	Ogden et al.	Jan 2005	B2
6843980	Green	Jan 2005	B2
6844153	Waldman et al.	Jan 2005	B2
6846320	Ashby et al.	Jan 2005	B2
6846650	Recipon et al.	Jan 2005	B2
6846911	Kelly	Jan 2005	B2
6847841	El Hatw	Jan 2005	B1
6849080	Lee et al.	Feb 2005	B2
6850588	Arenson et al.	Feb 2005	B2
6852528	Yu et al.	Feb 2005	B2
6855517	Salceda et al.	Feb 2005	B2
6855554	Fritsche et al.	Feb 2005	B2
6858412	Willis et al.	Feb 2005	B2
6858598	McKearn et al.	Feb 2005	B1
6858711	McGall et al.	Feb 2005	B2
6859049	Khatchatrian et al.	Feb 2005	B2
6860855	Shelby et al.	Mar 2005	B2
6860860	Viola	Mar 2005	B2
6863676	Lee et al.	Mar 2005	B2
6864224	Sedivy et al.	Mar 2005	B1
6866630	Larson et al.	Mar 2005	B2
6866993	Williamson	Mar 2005	B1
6866994	Morton	Mar 2005	B2
6867016	Billing-Medel et al.	Mar 2005	B1
6867753	Chinthammit et al.	Mar 2005	B2
6871086	Nevo et al.	Mar 2005	B2
6872184	Brannon	Mar 2005	B2
6872185	Fisher	Mar 2005	B2
6872389	Faris	Mar 2005	B1
6875182	Wardle et al.	Apr 2005	B2
6875184	Morton et al.	Apr 2005	B2
6883194	Corbeil et al.	Apr 2005	B2
6883958	Mayer	Apr 2005	B2
6884578	Warrington et al.	Apr 2005	B2
6884605	Hermonat et al.	Apr 2005	B2
6887210	Quay	May 2005	B2
6888919	Graf	May 2005	B2
6890308	Islam	May 2005	B2
6890309	Fisher	May 2005	B2
6890311	Love et al.	May 2005	B2
6890749	Billing-Medel et al.	May 2005	B2
6893818	Afar et al.	May 2005	B1
6893868	Packard et al.	May 2005	B2
6894026	Quay	May 2005	B1
6899696	Morton et al.	May 2005	B2
6900015	Avihingsanon et al.	May 2005	B2
6900049	Yu et al.	May 2005	B2
6901278	Notelovitz	May 2005	B1
6904305	Tsekos	Jun 2005	B2
6904309	Derendorf et al.	Jun 2005	B2
6905475	Hauschild et al.	Jun 2005	B2
6908440	Fisher	Jun 2005	B2
6913882	Glynne et al.	Jul 2005	B2
6914130	Gao et al.	Jul 2005	B2
6916800	McKearn et al.	Jul 2005	B2
6916918	Yu et al.	Jul 2005	B2
6918881	Miller et al.	Jul 2005	B2
6919176	Yang et al.	Jul 2005	B2
6920347	Simon et al.	Jul 2005	B2
RE38776	Bauer	Aug 2005	E
6923809	Eggers et al.	Aug 2005	B2
6924094	Gingeras et al.	Aug 2005	B1
6925389	Hitt et al.	Aug 2005	B2
6926893	Hansen	Aug 2005	B1
6927032	Lockhart et al.	Aug 2005	B2
6933105	Jin	Aug 2005	B2
6936014	Vetter et al.	Aug 2005	B2
6936416	Zhu et al.	Aug 2005	B2
6936687	Komoriya et al.	Aug 2005	B1
6942985	Waldman	Sep 2005	B2
6943236	Xu et al.	Sep 2005	B2
6944505	Zhang et al.	Sep 2005	B2
6945942	Van Bladel et al.	Sep 2005	B2
6947584	Avila et al.	Sep 2005	B1
6949357	Billing-Medel et al.	Sep 2005	B2
6953691	Reed et al.	Oct 2005	B2
6954667	Treado et al.	Oct 2005	B2
6955653	Eggers	Oct 2005	B2
6965793	Treado et al.	Nov 2005	B2
6994712	Fisher et al.	Feb 2006	B1
D518175	Hardin, Jr. et al.	Mar 2006	S
7014610	Koulik	Mar 2006	B2
7025765	Balbierz et al.	Apr 2006	B2
7067111	Yang et al.	Jun 2006	B1
7067274	Fairbrother et al.	Jun 2006	B2
7070816	Newmark et al.	Jul 2006	B2
7072704	Bucholz	Jul 2006	B2
7074600	Dean et al.	Jul 2006	B2
7077842	Cosman	Jul 2006	B1
7079132	Sauer et al.	Jul 2006	B2
7081340	Baker et al.	Jul 2006	B2
7083547	LaStayo et al.	Aug 2006	B2
7083985	Hefti et al.	Aug 2006	B2
7087393	Billing-Medel et al.	Aug 2006	B2
7089121	Wang	Aug 2006	B1
7090845	Fong et al.	Aug 2006	B2
7090862	Barrett-Reis et al.	Aug 2006	B2
7091047	Serrero	Aug 2006	B2
7094233	Desinger	Aug 2006	B2
7101663	Godfrey et al.	Sep 2006	B2
7101862	Cochrum et al.	Sep 2006	B2
7108969	Warrington et al.	Sep 2006	B1
7115368	Powers et al.	Oct 2006	B2
7118876	Tyner et al.	Oct 2006	B2
7118910	Unger et al.	Oct 2006	B2
7122011	Clifford et al.	Oct 2006	B2
7122653	Cohen et al.	Oct 2006	B2
7125836	Woodward	Oct 2006	B2
7125969	Benz et al.	Oct 2006	B1
7128877	Quay et al.	Oct 2006	B2
7128893	Leamon et al.	Oct 2006	B2
7129048	Bruchez et al.	Oct 2006	B2
7131951	Angel	Nov 2006	B2
7135333	Waldman et al.	Nov 2006	B1
7139601	Bucholz et al.	Nov 2006	B2
7141019	Pearlman	Nov 2006	B2
7144950	Bazan et al.	Dec 2006	B2
7153700	Pardee et al.	Dec 2006	B1
7156814	Williamson, IV et al.	Jan 2007	B1
7156815	Leigh et al.	Jan 2007	B2
7160292	Moorman et al.	Jan 2007	B2
7161057	Kneteman et al.	Jan 2007	B2
7169114	Krause	Jan 2007	B2
7172558	Olson, Jr.	Feb 2007	B2
7172739	Maughan	Feb 2007	B2
7175839	Hiserodt	Feb 2007	B1
7183251	Russo et al.	Feb 2007	B1
D538933	Andrade	Mar 2007	S
7186522	Lapen et al.	Mar 2007	B2
7189206	Quick et al.	Mar 2007	B2
7189207	Viola	Mar 2007	B2
7190378	Sauer et al.	Mar 2007	B2
7192570	Maecke et al.	Mar 2007	B2
7195774	Carvalho et al.	Mar 2007	B2
7195868	Iartchouk et al.	Mar 2007	B2
7195911	Cech et al.	Mar 2007	B2
7196182	Reed et al.	Mar 2007	B2
7198896	Rush et al.	Apr 2007	B2
7199234	Morin et al.	Apr 2007	B2
7204988	Cheung	Apr 2007	B2
7207985	Duong et al.	Apr 2007	B2
7208146	Denney, Jr.	Apr 2007	B2
7208267	Salceda et al.	Apr 2007	B2
7211398	Astle et al.	May 2007	B2
7214489	Bazan et al.	May 2007	B2
7217276	Henderson et al.	May 2007	B2
7217394	Studer	May 2007	B2
7218959	Alfano et al.	May 2007	B2
7220258	Myhr	May 2007	B2
7220891	Barsky et al.	May 2007	B2
7223238	Swanborn	May 2007	B2
7223380	Yang et al.	May 2007	B2
7223540	Pourmand et al.	May 2007	B2
7223542	Raitano et al.	May 2007	B2
7226731	Chuaqui et al.	Jun 2007	B1
7227009	Craik et al.	Jun 2007	B2
7229413	Violante et al.	Jun 2007	B2
7229417	Foerster et al.	Jun 2007	B2
7229439	Burbank et al.	Jun 2007	B2
7229604	Yang et al.	Jun 2007	B2
7229774	Chinnaiyan et al.	Jun 2007	B2
7231015	Kumakhov	Jun 2007	B2
7235047	MacAulay et al.	Jun 2007	B2
7236816	Kumar et al.	Jun 2007	B2
7241736	Hunter et al.	Jul 2007	B2
7244619	Contreras et al.	Jul 2007	B2
7245748	Degani et al.	Jul 2007	B2
7245958	Navab et al.	Jul 2007	B1
7247426	Yakhini et al.	Jul 2007	B2
7250180	Arellano	Jul 2007	B2
7250264	Fong et al.	Jul 2007	B2
7250551	Tsai et al.	Jul 2007	B2
7251352	Sauer et al.	Jul 2007	B2
7251568	Pittman et al.	Jul 2007	B2
7252935	Sidransky	Aug 2007	B2
7252946	Szasz	Aug 2007	B2
7252948	Gingeras et al.	Aug 2007	B2
7258973	Astle et al.	Aug 2007	B2
7261712	Burbank et al.	Aug 2007	B2
7261875	Li et al.	Aug 2007	B2
7262288	Cech et al.	Aug 2007	B1
7264947	Gozes et al.	Sep 2007	B2
7270956	Bazan et al.	Sep 2007	B2
7271187	Neuberger et al.	Sep 2007	B2
7274810	Reeves et al.	Sep 2007	B2
7314481	Karpiel	Jan 2008	B2
7608056	Kennedy, II	Oct 2009	B2
8109953	King, III et al.	Feb 2012	B1
D657461	Schembre et al.	Apr 2012	S
8162958	Takahashi et al.	Apr 2012	B2
8187203	McClellan	May 2012	B2
8262680	Swain et al.	Sep 2012	B2
8328772	Kinast et al.	Dec 2012	B2
8357193	Phan et al.	Jan 2013	B2
8361041	Fang et al.	Jan 2013	B2
8454632	Binmoeller et al.	Jun 2013	B2
8486010	Nomura	Jul 2013	B2
D690009	Schembre et al.	Sep 2013	S
8968210	Mugan et al.	Mar 2015	B2
9782565	McWeeney	Oct 2017	B2
20010007925	Ritchart et al.	Jul 2001	A1
20010023322	Espositio et al.	Sep 2001	A1
20010047183	Privitera et al.	Nov 2001	A1
20010056218	Hogendijk et al.	Dec 2001	A1
20020035324	Sirimanne et al.	Mar 2002	A1
20020082519	Miller et al.	Jun 2002	A1
20020156395	Stephens et al.	Oct 2002	A1
20020169418	Menzi et al.	Nov 2002	A1
20030078502	Miyaki et al.	Apr 2003	A1
20030093007	Wood	May 2003	A1
20030105488	Chu	Jun 2003	A1
20030139752	Pasricha	Jul 2003	A1
20030163142	Paltieli et al.	Aug 2003	A1
20030181823	Gatto	Sep 2003	A1
20030195436	Van Bladel et al.	Oct 2003	A1
20030204137	Chesbrough et al.	Oct 2003	A1
20030208134	Secrest et al.	Nov 2003	A1
20030208219	Aznoian et al.	Nov 2003	A1
20030212394	Pearson et al.	Nov 2003	A1
20030233101	Lubock et al.	Dec 2003	A1
20040073219	Skiba et al.	Apr 2004	A1
20040077948	Violante et al.	Apr 2004	A1
20040153005	Krueger	Aug 2004	A1
20040167429	Roshdieh et al.	Aug 2004	A1
20040236212	Jones et al.	Nov 2004	A1
20040249278	Krause	Dec 2004	A1
20040249395	Mikkaichi et al.	Dec 2004	A1
20040260199	Hardia et al.	Dec 2004	A1
20040260274	Hardin	Dec 2004	A1
20050021003	Caso et al.	Jan 2005	A1
20050022493	Olinger et al.	Feb 2005	A1
20050061697	Moberg	Mar 2005	A1
20050090801	Racz et al.	Apr 2005	A1
20050113715	Schwindt et al.	May 2005	A1
20050143753	Whitmore et al.	Jun 2005	A1
20050159676	Taylor et al.	Jul 2005	A1
20050192535	Takagi et al.	Sep 2005	A1
20050197623	Leeflang	Sep 2005	A1
20050228311	Beckman et al.	Oct 2005	A1
20050228312	Surti	Oct 2005	A1
20050228413	Binmoeller et al.	Oct 2005	A1
20050251111	Saito et al.	Nov 2005	A1
20050256426	Brugge	Nov 2005	A1
20050272975	McWeeney et al.	Dec 2005	A1
20060052750	Lenker et al.	Mar 2006	A1
20060100654	Fukuda et al.	May 2006	A1
20060116605	Nakao	Jun 2006	A1
20060142789	Lehman et al.	Jun 2006	A1
20060155210	Beckman et al.	Jul 2006	A1
20060167416	Mathis et al.	Jul 2006	A1
20060189891	Waxman et al.	Aug 2006	A1
20060235298	Kotmel et al.	Oct 2006	A1
20060247530	Hardin et al.	Nov 2006	A1
20060258955	Hoffman et al.	Nov 2006	A1
20060264919	Schaaf	Nov 2006	A1
20070023304	Joyce et al.	Feb 2007	A1
20070032741	Hibner et al.	Feb 2007	A1
20070038089	Hatano et al.	Feb 2007	A1
20070055173	DeLonzor et al.	Mar 2007	A1
20070056360	Grant et al.	Mar 2007	A1
20070060837	Cho et al.	Mar 2007	A1
20070118049	Viola	May 2007	A1
20070123799	Meireles	May 2007	A1
20070123800	Nishtala et al.	May 2007	A1
20070149893	Heske et al.	Jun 2007	A1
20070177009	Bayer et al.	Aug 2007	A1
20070179403	Heske et al.	Aug 2007	A1
20070185411	Hibner	Aug 2007	A1
20070213633	McClellan	Sep 2007	A1
20070213634	Teague	Sep 2007	A1
20070260258	Sommerich	Nov 2007	A1
20070282358	Remiszewski	Dec 2007	A1
20070299306	Parasher et al.	Dec 2007	A1
20080058637	Fischell et al.	Mar 2008	A1
20080097344	McKinnon et al.	Apr 2008	A1
20080097572	Sheldon et al.	Apr 2008	A1
20080146962	Ritchie et al.	Jun 2008	A1
20080147010	Nakajima et al.	Jun 2008	A1
20080200912	Long	Aug 2008	A1
20080294111	Tal et al.	Nov 2008	A1
20080300462	Intoccia et al.	Dec 2008	A1
20080319341	Taylor et al.	Dec 2008	A1
20090054773	Shizuka	Feb 2009	A1
20090064999	Marten	Mar 2009	A1
20090069679	Hibi	Mar 2009	A1
20090099414	Goto et al.	Apr 2009	A1
20090177114	Chin et al.	Jul 2009	A1
20090182200	Golden et al.	Jul 2009	A1
20090264794	Kodama	Oct 2009	A1
20090312645	Weitzner	Dec 2009	A1
20100081965	Mugan et al.	Apr 2010	A1
20100121218	Mugan et al.	May 2010	A1
20100274085	Mugan et al.	Oct 2010	A1
20110054381	Van Dam et al.	Mar 2011	A1
20110071350	Van Dam et al.	Mar 2011	A1
20110137394	Lunsford et al.	Jun 2011	A1
20110152886	Sato et al.	Jun 2011	A1
20120029278	Sato et al.	Feb 2012	A1
20120116248	McWeeney et al.	May 2012	A1
20120136426	Phan et al.	May 2012	A1
20120157880	Haselby et al.	Jun 2012	A1
20120172896	Takahashi et al.	Jul 2012	A1
20120245486	Melchiorri et al.	Sep 2012	A1
20120253228	Schembre et al.	Oct 2012	A1
20120296257	Van Dam et al.	Nov 2012	A1
20130041286	Theobald et al.	Feb 2013	A1
20130110141	Chmura	May 2013	A1
20130131547	Hardert et al.	May 2013	A1
20130131548	McGhie et al.	May 2013	A1
20130253546	Sander et al.	Sep 2013	A1
20130253550	Beisel et al.	Sep 2013	A1
20130310833	Brown et al.	Nov 2013	A1
20130325038	Sato	Dec 2013	A1
20140005478	Kennedy, II et al.	Jan 2014	A1
20140088684	Paskar	Mar 2014	A1

Foreign Referenced Citations (52)

Number	Date	Country
0704189	Apr 1996	EP
0738501	Oct 1996	EP
0739640	Oct 1996	EP
1870051	Dec 2007	EP
2030574	Mar 2009	EP
09818508	Apr 2010	EP
6-189965	Jul 1994	JP
7-116169	May 1995	JP
8-38482	Feb 1996	JP
9-135836	May 1997	JP
2003-245358	Sep 2003	JP
2005-58431	Mar 2005	JP
2006218070	Mar 2006	JP
2007-513692	May 2007	JP
2007-513692	May 2007	JP
201339219	Feb 2013	JP
201494241	May 2014	JP
86005324	Sep 1986	WO
92000039	Jan 1992	WO
9204062	Mar 1992	WO
00009178	Feb 2000	WO
0033909	Jun 2000	WO
00046626	Aug 2000	WO
2004066828	Aug 2004	WO
2004066829	Aug 2004	WO
2004073509	Sep 2004	WO
2005020905	Mar 2005	WO
2005060835	Jul 2005	WO
2005081032	Sep 2005	WO
2005081033	Sep 2005	WO
2005096953	Oct 2005	WO
2005096963	Oct 2005	WO
2005112797	Dec 2005	WO
2005120345	Dec 2005	WO
2006014011	Feb 2006	WO
2006028281	Mar 2006	WO
2006057443	Jun 2006	WO
2006064972	Jun 2006	WO
2007021904	Feb 2007	WO
2007021904	Feb 2007	WO
2007081039	Jul 2007	WO
2007-081041	Jul 2007	WO
2007081050	Jul 2007	WO
2007081056	Jul 2007	WO
2008020157	Feb 2008	WO
2008020439	Feb 2008	WO
2008024684	Feb 2008	WO
2008044013	Apr 2008	WO
2010039955	Apr 2010	WO
2010062895	Jun 2010	WO
2012112202	Aug 2012	WO
2013074653	May 2013	WO

Non-Patent Literature Citations (9)

Entry
Creganna Needle Brochure dated Jan. 16, 2008.
Iglesias-Garcia, 2011, Feasibility and Yield of a New EUS Histology Needle; Results from a Multicenter, Pooled Cohort Study, Gastrointestinal Endoscopy 73(6); 1189-1196.
Iwashita, 2013, High Single-pass diagnostic yield of a New 25-gauge core biopsy needle for EUS-guided FNA biopsy in solid pancreatic lesions, Gastrointestinal Endoscopy 77(6); 909-915.
Kahaleh, 2013, Endoscopic Ultrasonography Guided biliary drainage: Summary of consortium meeting; May 7, 2011, Chicago, World Journal of Gastroenterology, 19(9); 1372-1379.
Khashab, 2013, EUS-guided biliary drainage by using a standardized approach for malignant biliary obstruction: rendezvous versus direct transluminal techniques, Gastrointestinal Endoscopy; 1-8.
Park, 2011, EUS-guided biliary drainage with transluminal stenting after failed ERCP: predictors of adverse events and long-term results, Gastrointestinal Endoscopy 74(6); 1276-1284.
Park, 2013, Prospective evaluation of a treatment algorithm with enhanced guidewire manipulation protocol for EUS-guided biliary drainage after failed ERCP, Gastrointestinal Endoscopy 78(1); 92-101.
Pelaez-Luna, 2008, Interventional EUS guided cholangiography. First description in Mexico of a novel, secure and feasible technique. A case report, Caso Clinico.
Examiner's Report for Canadian Application No. 2,995,281 dated Oct. 19, 2018.

Related Publications (1)

	Number	Date	Country
	20180001057 A1	Jan 2018	US

Provisional Applications (4)

Number	Date	Country
61305304	Feb 2010	US
61305396	Feb 2010	US
61117966	Nov 2008	US
61152741	Feb 2009	US

Continuations (1)

	Number	Date	Country
Parent	14494685	Sep 2014	US
Child	15708882		US

Continuation in Parts (4)

	Number	Date	Country
Parent	13297766	Nov 2011	US
Child	14494685		US
Parent	13029593	Feb 2011	US
Child	13297766		US
Parent	12607636	Oct 2009	US
Child	13029593		US
Parent	12243367	Oct 2008	US
Child	12607636		US

Endoscopic ultrasound-guided biliary access system

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Disclaimer

Term Extension

Abstract